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Chapter 1 
 
 
General Introduction 
 
1.1. The endocrine control systems for lactation of dairy cows 
Dairy cows produce milk through the use of nutrients derived from ingested 
feeds and mobilized body tissues when their energy intake is insufficient.  The 
metabolic processes partitioning nutrients to milk are important factors to determine 
milk yield for lactating dairy cows, and are under the endocrine control of several 
metabolic hormones.  In particular, growth hormone (GH) plays a primary role in 
increasing milk production for lactating dairy cows (Peel et al., 1982; Burton et al., 
1994 [Figure 1-1]).  GH stimulates gluconeogenesis in the liver and lipolysis in the 
adipose tissue, to provide energy and a substrate of milk fat synthesis (Bauman and 
Currie, 1980).  Simultaneously, GH increases plasma insulin-like growth factor-1 
(IGF-1) concentration (Davis et al., 1987), which enhances mammary gland blood flow 
in lactating ruminants (Prosser et al., 1990, 1994) and causes insulin resistance in the 
adipose and muscular tissues (Burton et al., 1994).  Numerous trials have confirmed 
the galactopoietic effects of recombinant bovine GH (rbGH), and 6-41% increases in 
milk yield were observed (Burton and McBride, 1989; Bauman and Vernon, 1993; 
Bauman et al., 1985).  In the United States, the usage of rbGH are permitted for 
increasing milk production, whereas it has not been allowed on the market in Japan, 
Canada, Australia, New Zealand, Israel and all European Union countries with 
consumer’s concern over safety and security of food.  Therefore, it is necessary to 
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develop the management systems for improving the production efficiency without 
relying on exogenous administration of rbGH. 
 
 
Figure 1-1 
 
The galactopoietic effects of GH and association with ghrelin. 
 
 
1.2. Ghrelin: a novel GH-releasing peptide derived from the gastrointestinal tract 
GH release is stimulated by hypothalamic GH-releasing hormone (GHRH) and 
inhibited by somatostatin (Anderson et al., 2004).  Recently, however, the third 
independent pathway regulating GH release has been identified from the studies on GH 
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secretagogues (GHSs).  Using a reverse pharmacology paradigm with a stable cell line 
expressing GHS receptor (GHS-R), Kojima et al. (1999) found a novel endogenous 
ligand for GHS-R from rat stomach, and named it ghrelin.  Ghrelin can potently 
stimulate GH secretion from the pituitary gland (Kojima et al., 1999; Takaya et al., 
2000).  In addition, ghrelin has been found in the hypothalamic arcuate nucleus, an 
important region for controlling appetite (Kojima et al., 1999).  This suggests that 
ghrelin play a role in controlling food intake.  In fact, injection of ghrelin into the 
cerebral ventricles of rats potently stimulates food intake (Nakazato et al., 2001).  
Therefore, ghrelin may have some preferable effects for lactating cows. 
 
 
1.3. Ghrelin secretion and function in ruminants 
Ghrelin is mainly secreted by the abomasum in ruminants (Hayashida et al., 
2001) and can stimulate GH secretion (Itoh et al., 2005; Hosoda and Kangawa, 2008; 
Fukumori et al., in press-b).  Plasma ghrelin concentration is related to the feeding and 
nutritional status of ruminants (Sugino et al., 2004).  In lactating cows, negative energy 
balance increases periprandial ghrelin concentrations (Bradford and Allen, 2008).  
Sugino et al. (2006) showed that plasma ghrelin concentration increased at postpartum 
and a variation of plasma GH concentration was related to the change of ghrelin in dairy 
cows.  In addition, the ghrelin-induced GH secretion might be augmented during early 
lactating period (Itoh et al., 2005).  Additionally, Itoh et al. (2006) reported that ghrelin 
increased plasma pancreatic hormones and glucose levels during only lactating period.  
Roche et al. (2008) also reported that long-term infusion of ghrelin increased plasma 
non-esterified fatty acids (NEFA) concentration in lactating cows.  Thus, ghrelin could 
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play an important role to regulate the secretion and action of metabolic hormones, 
changing the nutrient metabolism for milk production in lactating cows. 
 
 
1.4. Effects of nutrients on plasma ghrelin concentration in ruminants 
     Plasma ghrelin concentrations are related to feeding; A preprandial rise and a 
postprandial fall in circulating ghrelin concentrations have been observed in humans 
(Cummings et al., 2002) and sheep (Sugino et al., 2002).  Some reports propose that 
circulating metabolites affect the depression of circulating ghrelin concentrations.  In 
non-ruminants, both oral and intravenous doses of glucose depressed plasma ghrelin 
concentrations (Nakagawa et al., 2002, Shiiya et al., 2002).  In ruminants, however, the 
major energy substrate is volatile fatty acids (VFA).  Therefore, it is likely that the 
inhibiting factor for ghrelin secretion may differ between non-ruminants and ruminants.  
In fact, VFA (acetate, propionate and butyrate) injections depressed plasma ghrelin 
concentrations in wethers and calves (Fukumori et al., 2011; Fukumori et al., in press-a), 
while glucose injection did not depress in sheep and calves (Sugino et al., 2010; 
Fukumori et al., in press-a).  In addition, a high-protein diet consumed sheep showed 
higher plasma ghrelin concentration compared with a low-protein diet in sheep 
(Takahashi et al., 2009), and the intravenous infusion of amino acids increased plasma 
ghrelin concentration in sheep (Sugino et al., 2010).  These results suggest that 
available amino acids can increase plasma ghrelin concentration.  Furthermore, plasma 
ghrelin concentration was raised by feeding medium chain fatty acids in rat (Nishi et al., 
2005).  Additionally, the previous study using lactating ewes showed feeding 
long-chain fatty acids with methionine increased milk production with an increase in 
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DMI (Goulas et al., 2003).  Thus, it was hypothesized that medium-chain and 
long-chain fatty acids with methionine would be effective to increase plasma ghrelin 
concentration, although the effects of these nutrients on plasma ghrelin concentration 
had not been proved in ruminants.  The nutritional strategies modifying the supply of 
amino acids and fatty acids to control plasma ghrelin concentration may result in the 
preferable milk production via alterations of plasma GH and pancreatic hormone 
concentrations.  Therefore, the objectives of this study were to determine the effect of 
nutrients on secretion and action of ghrelin, and relationship with milk production in 
lactating dairy cows including three sub-objectives: 
 
Sub-objective 1: 
To determine the effects of amino acids on plasma ghrelin concentration, and to 
elucidate the ghrelin action inducing GH, glucagon and insulin secretion in lactating 
cows. 
 
Sub-objective 2: 
To determine the effects of medium-chain fatty acids on plasma concentration and 
action of ghrelin, and to investigate the interaction of metabolic hormones, metabolites 
and milk production in lactating cows. 
 
Sub-objective 3: 
To determine the effects of long-chain fatty acids plus methionine on plasma ghrelin 
concentration, and to investigate the interaction of metabolic hormones, metabolites and 
milk production in lactating cows. 
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The nutritional strategy that focused on regulating endogenous hormone secretion 
to get efficient production is an unique attempt.  These new findings would contribute 
to understand ghrelin secretion and its role in regulating lactation performance of dairy 
cows.   
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Chapter 2 
 
 
Effects of Intravenous Infusion of Amino Acids on Plasma Ghrelin 
Concentration, and GH, Insulin and Glucagon Secretion Induced by 
Ghrelin Injection in Lactating Dairy Cows            
 
2.1. Introduction 
The relationship between available nutrients and ghrelin secretion was 
documented in several published papers.  A high protein diet increased ghrelin plasma 
levels in rats (Vallejo-Cremades et al., 2004), and oral low-dose of an essential amino 
acid mixture increased plasma ghrelin concentration in fasting humans (Knerr et al., 
2003).   In sheep, the intravenous infusion of an amino acid mixture also increased 
plasma ghrelin concentration in sheep (Sugino et al., 2010).  These previous results 
suggest that amino acids possibly increase plasma ghrelin concentration in lactating 
cows.  Therefore, the objective of the present study was to investigate the effect of 
amino acids infusion into the jugular vein on plasma ghrelin concentration in lactating 
dairy cows.  Additionally, nutrient availability may affect ghrelin action.  Itoh et al. 
(2006) demonstrated that ghrelin injection increased plasma GH, glucagon, insulin and 
glucose concentrations during the lactating period of dairy cows.  Thus, the second 
aim of this study was to determine the effect of amino acids on ghrelin action in 
regulating GH secretion, pancreatic hormone secretion and nutrients (glucose and 
NEFA) metabolism in lactating dairy cows.  
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2.2. Materials and Method 
The procedures used in the present study were carried out in accordance with the 
principles and guidelines for animal use issued by the National Institute of Livestock 
and Grassland Science Animal Care Committee, and which were formulated to comply 
with Japanese regulations. 
 
2.2.1. Animals  
Six lactating Holstein cows [calving number: 3.3 ± 0.8, initial days in milk 
(DIM): 57.2 ± 2.1, initial body weight (BW): 687 ± 18 kg] were fed a diet according to 
the Japanese Feeding Standard for Dairy Cattle (Agriculture, Forestry, and Fisheries 
Research Council Secretariat, 2006), twice daily (0900 h and 1800 h).  The cows 
were allowed free access to the diet and water.  Refusals were weighed daily before 
the morning feeding.  The crude protein (CP) and total digestible nutrient (TDN) 
contents in the diet and the level of TDN offered were 13.0% and 69.8% on the dry 
matter (DM) basis, respectively.  Cows were milked twice daily before each feeding.  
The daily DM intake, milk yield, TDN and CP sufficiency through the experiment 
were 23.1 ± 1.0 kg, 32.5 ± 0.4 kg, 105.7 ± 3.5% and 97.0 ± 4.3%, respectively.  The 
cows were inserted chronic catheters (Argyle 14 G CV catheter kit; Nippon Sherwood 
Medical Industries Ltd., Tokyo, Japan) into both sides of the jugular vein at least 1 day 
before the first treatment. These catheters were used for both reagent infusion and 
blood sampling. 
 
2.2.3. Treatments and blood sampling 
Cows were randomly given two infusion treatments with mixture solution of 
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amino acids [AMI: Aminic (Ajinomoto Pharmaceuticals Co., Ltd., Tokyo, Japan) plus 
methionine dissolved into saline, total amino acids: 91.1 mg/mL, infusion rate: 4.0 
mg/kg of metabolic body weight (BW0.75)/min] or saline (CON) in a cross-over design.  
Each treatment was carried out at least 1 week interval to avoid measurement values 
being affected by the previous treatment.  The amino acids composition of AMI is 
presented in Table 2-1.  The time schedule for the infusion and injection treatment, 
and the blood sampling is showed in Figure 2-1.  The infusion amount of AMI was 
equal to about 6% of the requirement of digestible crude protein (CP) and compensated 
for the lack of CP intake.  At 4 h after morning feeding (1300 h), a mixture solution 
of amino acids or saline was continuously infused into the jugular vein catheter on the 
left side.  The solutions were infused with a peristaltic pump (Model 312/MP-4; 
Gilson, Inc., Middleton, France) for 4 h.  At two hours after the initiation of AMI and 
CON infusion, synthetic bovine ghrelin (1 µg/kg BW; KNC Laboratories Co., Ltd., 
Kobe, Japan) was single dosed into the right side jugular vein through the catheter.  
This injection dose of ghrelin was chosen based on Itoh et al. (2006).  Their report 
demonstrated that a dose of ghrelin similar to that used in this study had clear effects 
on insulin and glucagon secretion in lactating cows.  After ghrelin injection, 10 mL of 
saline was injected for flushing the inner of the catheter.  Blood samples were taken at 
−130, −120, −10, 0, 5, 10, 15, 20, 25, 30, 40, 50, 60, 90, 120, 150 and 180 min relative 
to the ghrelin injection from the catheter of the right side jugular vein and collected 
into tubes containing heparin (10 U/mL of blood; Wako Pure Chemical Industries Ltd., 
Osaka, Japan) and aprotinine [500 kilo inhibitor unit (KIU)/mL of blood; Trasyrol, 
Bayer, Leverkusen, Germany].  The obtained blood samples were centrifuged at 
1,500 × g for 20 min at 4°C.  Harvested plasma was stored at −80°C prior to assay.  
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2.2.4. Sample analysis 
Plasma ghrelin, GH and insulin levels were measured with time-resolved 
fluoro-immunoassay (TR-FIA).  Assay for bioactive ghrelin and GH was conducted 
as described previously (Sugino et al., 2004).  The ghrelin concentration was 
measured by competitive solid-phase immunoassay using europium (Eu)-labeled 
synthetic rat ghrelin (Peptide Institute, Inc., Osaka, Japan) and polystyrene microtiter 
strips (Nalge Nunc Int., Tokyo, Japan) coated with anti-rabbit γ-globulin (Kitasato 
University, Aomori, Japan) and anti-rat ghrelin serum (National Cardiovascular Center 
Research Institute, Osaka, Japan).  The ghrelin antibody is particular with acylated 
ghrelin (positive form of ghrelin).  Intra- and inter-assay coefficients of variation were 
1.3 and 1.5%, respectively.  Least detectable dose in this assay system was 0.025 
ng/mL.  The GH concentration was measured by competitive solid-phase 
immunoassay using Eu-labeled synthetic ovine GH (NIDDK, Bethesda, USA) and 
polystyrene microtiter strips coated with anti-rabbit γ-globulin and anti-ovine GH 
serum (NIDDK, Bethesda, USA).  Intra- and inter-assay coefficients of variation were 
2.6 and 3.6%, respectively.  Least detectable dose in this assay system was 0.158 
ng/mL.  Insulin assay was conducted as described previously (Takahashi et al., 2006).  
The insulin concentration was measured by competitive solid-phase immunoassay 
using Eu-labeled synthetic bovine insulin (Sigma-Aldrich Inc., Tokyo, Japan) and 
polystyrene microtiter strips coated with anti-guinea pig γ-globulin (JAPAN LAMB 
CO., LTD., Hiroshima, Japan) and anti-human insulin serum (Yanaihara Institute Inc., 
Shizuoka, Japan).  Intra- and inter-assay coefficients of variation were 2.2 and 1.8%, 
respectively.  Least detectable dose in this assay system was 0.016 ng/mL.  
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Plasma glucagon concentration was measured using commercially available 
radioimmunoassay kit (glucagon assay kit; Daiichi Radioisotope Laboratories Ltd., 
Tokyo, Japan).  Glucagon concentration was measured in the same assay, and the 
intra-assay coefficient of variation was 3.4%.  Least detectable dose was 1.5 × 10-5 
ng/mL. 
Plasma glucose concentrations were determined using a glucose analyzer 
(GA-1151; Arkray, Inc., Kyoto, Japan).  Plasma alpha amino nitrogen (AAN) 
concentration was analyzed following the procedures of Goodwin (1968).  Plasma 
NEFA concentrations were determined with the commercially available kit (NEFA C 
test Wako; Wako Pure Chemical Industries, Ltd., Osaka, Japan). 
 
2.2.5. Calculations and statistics 
The values of plasma hormones and metabolites were expressed as means of six 
cows with standard error (SE).  The area under the curve (AUC) was calculated for 
hormones and metabolites after ghrelin injection over 0-60 min, 60-120 min and 
120-180 min terms.  The values were expressed as means of six cows with SE. Data 
were analyzed as a crossover design with a mixed linear model using restricted 
maximum likelihood by the JMP program package (version 5.01 for Windows 
computer system, SAS Institute, Inc., Cary, NC, USA).  Dependent variables were 
summarized as least squares means and least squares SE.  The model included the 
treatment, time and the interaction between treatment and time as the fixed effects, and 
cow and period as the random effects.  The temporal changes of the concentrations 
for each infusion treatment were evaluated by multiple comparisons with Tukey’s test.  
The differences in plasma concentrations at each time and AUC at each term between 
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CON and AMI were evaluated by Student’s t-test.  P < 0.05 was considered 
significant. 
 
 
2.3. Results and Discussion 
 
In rats, ghrelin expression and secretion were enhanced by feeding of a high 
protein diet (Vallejo-Cremades et al., 2004; 2005).  Knerr et al. (2003) reported that 
oral low-dose of essential amino acid mixture bolus elicited hyper-aminoacidemia and 
an increased ghrelin secretion in fasting humans.  In sheep, plasma ghrelin 
concentrations were increased by abomasal infusion of casein plus starch (Sugino et al., 
2010).  Thus, the absorption of amino acids may be one of the stimulating factors of 
ghrelin secretion in both ruminant and non-ruminant animals.  In addition, a recent 
study demonstrated that the intravenous infusion of amino acids increased plasma 
ghrelin concentrations in sheep (Sugino et al., 2010).  These previous reports suggest 
that the increased circulating levels of amino acids may play a key role in enhanced 
ghrelin secretion.  In this study, the amino acid infusion increased plasma AAN 
concentration (pre-infusion: 0.328 mg N/dL, post-infusion: 0.462 mg N/dL, P < 0.05, 
Figure 2-2A) and AAN AUC was greater in AMI compared with CON (0-60 min; 
CON: 20.9 mg N･min/dL, AMI: 27.2 mg N･min/dL and 60-120 min; CON: 19.2 mg 
N･min/dL, AMI: 27.2 mg N･min/dL, P < 0.05, Figure 2-4A), but did not affect the 
plasma ghrelin concentration (Figures 2-3A, 2-5A).  Sugino et al. (2010) 
demonstrated that more than 66% rise of plasma AAN concentration stimulated ghrelin 
secretion, but not in 27% rise of plasma AAN concentration.  In the present study, 
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41% rise of plasma AAN levels by amino acids infusion has not changed plasma 
ghrelin levels in lactating cows.  The present study examined the effect of the amino 
acid infusion under the deficient of CP intake (97%) to make the infusion effective.  
The infusion amount of amino acids was the extent to compensate for the shortage of 
the feed.  On the other hand, previous reports tested more extreme differences 
between control and treatment (Sugino et al., 2010; Takahashi et al., 2009).  
Takahashi et al. (2009) examined high-CP diet (40%) versus low-CP diet (10%) in 
wethers, resulting high-CP diet tended to increase plasma ghrelin concentration.  The 
infusion amount of amino acid by Sugino et al. (2010) was equal to about 60% of the 
requirement of digestible CP.  Thus, the infusion amount of amino acids in the present 
study would be too low to increase plasma ghrelin concentration.  The types of amino 
acids may be also an important factor for ghrelin secretion.  Kuhara et al. (1991), who 
infused intravenously 17 kinds of amino acids at the each dose of 3.0 mmol/kgBW 
over 30 min, observed that acidic amino acids stimulated GH secretion, neutral amino 
acids stimulated insulin secretion, and neutral straight-chain amino acids stimulated 
glucagon secretion in sheep.  The total amount of the mixture of amino acids was 
nearly equal level (2.68 mmol/kgBW over 120 min) with the study by Kuhara et al 
(1991), but the infusion level of each amino acid was lower, which might be the reason 
of no response of GH, insulin and glucagon to AMI observed in the present experiment.  
There may be a threshold level of plasma AAN and the kind of amino acid stimulating 
ghrelin and metabolic hormone secretion.   
Plasma ghrelin concentration increased after ghrelin injection (P < 0.05, Figure 
2-3A) with no difference between CON and AMI (Figures 2-3A, 2-5A).  Plasma GH 
concentrations were increased by ghrelin injection in both treatments (P < 0.05, Figure 
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2-3B).  Plasma GH concentration peaked at 5 min after ghrelin injection, and then 
decreased to the basal level within 50 min in both treatments.  The GH secretory 
response to ghrelin was not different between both treatments (Figures 2-3B, 2-5B).  
Takahashi et al. (2009) reported that ghrelin stimulated GH secretion more in the 
satiety state than in the fasting state in sheep.  Thus, the GH secretory response to 
ghrelin might be affected by feeding states or energy balance.  The GH secretory 
response to ghrelin injection in this study was investigated under the same feeding 
state.  Thus, GH secretion by ghrelin injection likely did not be affected by the 
difference in the level of the circulating amino acids. 
Plasma glucagon concentration increased after ghrelin injection in both 
treatments (P < 0.05, Figure 2-3D).  Itoh et al. (2005) have reported that ghrelin 
enhanced glucagon secretion only in lactating cows and that ghrelin induced pancreatic 
glucagon secretion in diabetic rats, but not in normal rats (Adeghate and Parvez, 2002).  
This ghrelin action in stimulating glucagon secretion could be expressed when insulin 
resistance is enhanced under the conditions such as lactating or diabetes.  A 
significant increase of plasma glucagon concentration was observed at 5 min after 
ghrelin injection in both treatments, and thereafter, plasma glucagon concentrations 
rapidly declined in CON, but not in AMI (25 min; CON: 0.0896 ng/mL, AMI: 0.112 
ng/mL, P < 0.05, Figure 2-3D).  Consequently, glucagon AUC from 0 to 60 min in 
AMI was greater compared with CON (0-60 min; CON: 5.10 ng･min/mL, AMI: 6.13 
ng･min/mL, P < 0.05, Figure 2-5D).  In the current study, there was no effect of the 
amino acid infusion on plasma glucagon concentration before ghrelin injection.  
However, the rise of plasma glucagon concentration by ghrelin injection was 
augmented in AMI compared with CON.  Thus, it may be possible that the infused 
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amino acids enhance glucagon secretion through a ghrelin-dependent process.  In this 
study, however, such mechanism was unclear and further investigations are suggested 
for more clarification. 
Plasma glucose and NEFA concentrations increased after ghrelin injection in 
both treatments (P < 0.05, Figures 2-2B, 2-2C).  These responses were preceded by 
increased plasma GH and glucagon concentrations by ghrelin injection.  It is well 
known that GH and glucagon enhance glucose and NEFA release into the blood 
circulation through their gluconeogenic, glycogenolytic and lipolytic actions.  
Because ghrelin inhibits insulin signaling in skeletal muscle, liver, and fat tissue 
(Murata et al., 2002; Barazzoni et al., 2008), ghrelin-induced hyperglycemia may also 
be related to the limited peripheral glucose uptake and/or to the enhanced 
gluconeogenesis.  Although there has been no information about an acute response to 
ghrelin on plasma NEFA concentration, long-term infusion of ghrelin in lactating cows 
increased plasma NEFA concentration with no changes in plasma GH concentration 
(Roche et al., 2008).  In the present study, therefore, ghrelin injection possibly 
increased plasma glucose and NEFA concentrations via GH and glucagon. 
Plasma insulin concentration increased after ghrelin injection with observed 
higher peak at 10 min in AMI compared with CON (CON: 2.967 ng/mL, AMI: 3.875 
ng/mL, P < 0.05, Figure 2-3C), although insulin AUC was not significantly different 
between two infusion treatments (Figure 2-4C).  Although the increased plasma 
glucose and NEFA concentrations after ghrelin injection were not different in the peak 
values between CON and AMI (Figures 2-2B, 2-2C), the decline in plasma glucose 
concentration from 60 to 120 min was greater in AMI compared with CON (P < 0.05, 
Figures 2-2B, 2-3B).  The reason might be related to a greater insulin peak level in 
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AMI.  The insulin response followed the increases in plasma glucagon and glucose 
concentrations.  Glucagon stimulates insulin secretion directly by paracrine manner in 
the pancreas or via hyperglycemia by enhancing glucose release from the liver 
(Johnson et al., 1972).  Takahashi et al. (2006, 2007) demonstrated that intrajugular 
ghrelin administration stimulated glucose-induced insulin secretion in meal-fed sheep.  
In the present study, ghrelin might increase plasma glucagon and glucose 
concentrations, thereby enhancing insulin secretion.  Sugino et al. (2010) revealed 
that hyper-aminoacidemia and hyper-ghrelinemia enhanced glucose induced insulin 
secretion in sheep.  Thus, the high values of plasma insulin concentration in AMI 
might be resulted because of the high values of plasma AAN and ghrelin 
concentrations compared with CON. 
In conclusion, the increase in plasma AAN concentration may enhance ghrelin 
action to increase insulin and glucagon secretions into blood circulation without 
affecting plasma ghrelin concentration during lactating period in cows.  
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Table 2-1.　Composition of amino acids mixture
used in this study
Item w/v (%)
　L-valine         1.17
　L-leucine         1.08
　L-lysine acetate         0.833
　 L-isoleucine         0.758
　L-arginine         0.750
　L-threonine         0.625
　L-alanine         0.592
　Glycine         0.583
　L-phenylalanine         0.583
　L-proline         0.417
　L-histidine         0.417
　L-methionine         0.867
　L-serine         0.142
　L-tryptophan         0.108
　L-aspartate         0.0833
　L-glutamate         0.0417
　L-tyrosine         0.0333
　L-cystine         0.0292
　 Total amino acids         9.11
    Total N (mg/mL)       12.7
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Figure 2-1 
 
 
 
 
 
The time schedule of saline or amino acids infusion, ghrelin injection and blood sampling. 
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Figure 2-2 
 
 
Plasma AAN (A), glucose (B) and NEFA (C) concentrations in amino acids (AMI) and saline 
(CON) treatments before and after ghrelin injection.  Values are expressed as mean ± SE (vertical 
bar, n = 6).  Circles and triangles show the CON and AMI treatments, respectively.  *: P < 0.05 
compared between CON and AMI at each time.  Open plot: P < 0.05, difference between pre 
amino acids or saline infusion (mean values from −130 and −120 min).  The horizonal bar and 
arrow show the period of the amino acids or saline infusion period and ghrelin injection time, 
respectively. 
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Figure 2-3 
 
 
Plasma ghrelin (A), GH (B), insulin (C) and glucagon (D) concentrations in amino acids (AMI) and 
saline (CON) treatments before and after ghrelin injection.  Values are expressed as mean ± SE 
(vertical bar, n = 6).  Circles and triangles show the CON and AMI treatments, respectively.  *: P 
< 0.05 compared between CON and AMI at each time.  Open plot: P < 0.05, difference between 
pre amino acids or saline infusion (mean values from −130 and −120 min).  The horizonal bar and 
arrow show the period of the amino acids or saline infusion period and ghrelin injection time, 
respectively. 
 
 
 
21 
 
Figure 2-4 
 
The area under the curves (AUCs) of plasma AAN (A), glucose (B) and NEFA (C) concentrations 
over 0-60 min, 60-120 min and 120-180 min following ghrelin injection in amino acids (AMI) and 
saline (CON) treatments.  Values are expressed as mean ± SE (vertical bar, n = 6).  *: P < 0.05 
compared between CON and AMI at each period. 
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Figure 2-5 
 
 
The area under the curves (AUCs) of plasma ghrelin (A), GH (B), insulin (C) and glucagon (D) 
concentrations over 0-60 min, 60-120 min and 120-180 min following ghrelin injection in amino 
acids (AMI) and saline (CON) treatments.  Values are expressed as mean ± SE (vertical bar, n = 6).  
*: P < 0.05 compared between CON and AMI at each period. 
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Chapter 3 
 
 
Effects of Feeding Medium-Chain Fatty Acids on Plasma 
Concentration and Action of Ghrelin and Milk Production in 
Lactating Dairy Cows 
 
3.1. Introduction 
Ghrelin has a unique characteristic that it requires acylation with octanoate 
(C8:0) at its Ser 3 residue in order to become a proper ligand for its only known 
receptor, the growth hormone secretagogue receptor 1a (GHS-R1a) (Nakazato et al., 
2001).  In rats, medium-chain fatty acids (MCFA, C6:0–C12:0) ingestion increased 
stomach octanoyl ghrelin, whereas the amount of total ghrelin remained unchanged in 
rats (Nishi et al., 2005).  Kirchner et al. (2009) also showed an increase of more than 
double the concentration of octanoyl ghrelin in mice fed a medium-chain 
triglyceride-enriched diet.  These studies suggested that dietary MCFA are used 
directly in ghrelin acylation.  Therefore, MCFA ingestion can increase plasma 
octanoyl ghrelin concentration in lactating cows.  However, the effect of MCFA on 
plasma ghrelin concentration has not been examined in ruminants.  Furthermore, 
MCFA may be an energy supplement for lactating cows because they are rapidly 
metabolized in the body.  However, several reports showed that MCFA had adverse 
effects on ruminal fermentation (Dohme et al., 1999, 2001) and including MCFA in the 
diets as a triglyceride decreased dry matter intake (DMI) in lactating cows (Grummer 
and Socha, 1989; Reveneau et al., 2012).  MCFA, especially lauric acid (C12:0), 
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exhibit potent antiprotozoal properties and reduce ruminal methane production 
(Dohme et al., 1999, 2001).  Calcium salts of fatty acids are products aimed to 
depress the adverse effects on ruminal fermentation (Schneider et al., 1988) and 
several reports showed that calcium salts of long-chain fatty acids were used for 
lactating cows succeeded to avoid the adverse effect on ruminal fermentation (Schauff 
and Clark, 1989; Schneider et al., 1988).  Therefore, the aim of this study was to 
investigate the effect of calcium salts of MCFA (MCFA-Ca) on plasma ghrelin 
concentration.  Simultaneously, the present study evaluated the other metabolic and 
gastrointestinal hormones.  In this study, plasma GH, IGF-1, glucagon-like peptide-1 
(7-36) amide (GLP-1), glucagon and insulin concentrations were investigated as 
evaluating metabolic hormonal changes.  Additionally, MCFA ingestion may change 
ghrelin action as described in Chapter 2, and they may have some preferred effects on 
milk production.  GLP-1, secreted by the small intestine, stimulates insulin secretion 
(Kreymann et al., 1990; Fukumori et al., 2012-b; Hare et al., 2010).  Glucagon and 
insulin are closely related to nutrient metabolism and may contribute to milk 
production. 
In this study, the effects of the ingested MCFA-Ca on plasma concentration and 
action of ghrelin, and their relationship with milk production were evaluated in 
lactating cows. 
 
 
3.2. Materials and Methods 
The procedures used in the present study were carried out in accordance with the 
principles and guidelines for animal use issued by the National Institute of Livestock 
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and Grassland Science Animal Care Committee, and which were formulated to comply 
with Japanese regulations. 
 
3.2.1. Animals and Management  
Five multiparous Holstein cows (initial DIM: 73.6 ± 2.2, calving number: 2.6 ± 
0.4, initial BW: 572.6 ± 31.1 kg) were fed one of the two diets formulated to meet the 
nutrient requirements according to the Japanese Feeding Standard for Dairy Cattle 
(2006).  The ingredients and composition of the diets are presented in Table 3-1. The 
cows were managed in individual tie stalls, allowed free access to water, and provided 
experimental diets twice daily at 0900 and 1800 h.  They were milked twice daily 
before each feeding (0840 and 1740 h) and weighed every week. 
 
3.2.2. Treatments and Experimental Design 
The cows were randomly assigned to one of the two dietary treatments in a 
crossover design with 2-week periods.  One group was fed a diet supplemented with 
MCFA-Ca (Star mate; Yuka Sangyo Co., Ltd., Tokyo, Japan), and the other was fed the 
same diet without the supplement (control).  The MCFA-Ca containing 75% FAs (FA 
composition: C8:0, 25%; C10:0, 20%; and C12:0, 55%) was added to 1.5% of the 
dietary DM, following the protocol of a previous study (Fukumori et al., 2012-b).  
Cows were offered the food ad libitum, allowing for 10% refusal for the first 10 d for 
each treatment.  For the last 4 d of each period, the cows were fed 95% of ad libitum 
intake to maintain a constant metabolizable energy intake (MEI).   
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3.2.3. Sampling 
     Samples of the diets and refusals were collected and pooled for the last 4 d of 
each period.  Milk samples were collected for the last 4 d of each period.  Sodium 
azide was added as a preservative to these samples, and the samples were stored at 4°C 
until analyses of fat, protein, lactose, total solids (TS) and solid not fat (SNF).  Blood 
samples were taken on d 13 or d 14 from the jugular vein catheter (Argyle 14 G CV 
catheter kit; Nippon Sherwood Medical Industries Ltd., Tokyo, Japan) inserted on day 
13 of each period.  The blood samples (8 mL) were taken at 10-min intervals from 
0800 to 1100 h.  To evaluate ghrelin action, synthetic bovine ghrelin (0.5 µg/kgBW) 
was single dosed into the jugular vein through the catheter.  After ghrelin injection, 10 
mL of saline was injected for flushing the inner of the catheter.  Blood samples were 
taken at −10, 0, 1.5, 3, 4.5, 6, 9, 12, 15, 20, 25, 30, 40, 50, 60, 90 and 120 min relative 
to the ghrelin injection from the catheter.  The incremental area was calculated for 
hormones (GH, insulin and glucagon) and metabolites (glucose and NEFA) after 
ghrelin injection over 0-60 min and 60-120 min terms.  Collected blood samples were 
immediately placed in tubes containing heparin (10 U/mL of blood; Wako Pure 
Chemical Industries Ltd., Osaka, Japan) with aprotinin (500 KIU/mL of blood; 
Sigma-Aldrich Inc., Tokyo, Japan), and centrifuged at 1,500 ×g for 20 min at 4°C. 
Harvested plasma samples were stored at −80°C until assay.  
 
3.2.4. Sample Analysis 
     The diet samples and refusals were analysed for DM, CP, neutral detergent fiber 
(NDF), ether extract (EE) and crude ash contents according to the procedures of 
AOAC (1990).  Metabolizable energy (ME) and net energy (NE) contents in the 
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treatment diets were estimated by NRC (2001).  Retained energy was calculated with 
the following formula: Retained energy (Mcal/d) = NEintake – (NEmaintainance + 
NElactation). 
Milk samples were measured for fat, protein, lactose, TS and SNF by infrared 
analysis (Milko-Scan 1344 A/BN; Foss Electric Company Inc., Hillerød, Denmark).    
Plasma ghrelin, GH and insulin concentrations were measured as described at 
Chapter 2.2.4.  Plasma IGF-1 concentration was measured by TR-FIA using 
Eu-labeled human IGF-1 (GroPep bioreagents Pty Ltd., Adelaide, Australia) and 
polystyrene microtiter strips coated with anti-rabbit γ-globulin and anti-human IGF-1 
(GroPep bioreagents Pty Ltd., Adelaide, Australia).  Plasma GLP-1 concentration was 
measured by TR-FIA using Eu-labeled rat GLP-1 (Yanaihara Institute Inc., Shizuoka, 
Japan) and polystyrene microtiter strips coated with anti-rabbit γ-globulin and 
anti-human GLP-1 (Peptide Institute, Inc., Osaka, Japan).  Plasma glucagon 
concentration was measured by TR-FIA using Eu-labeled porcine glucagon 
(Sigma-Aldrich, Inc., Tokyo, Japan) and polystyrene microtiter strips coated with 
anti-guinea pig γ-globulin and anti-bovine glucagon (Acris Antibodies GmbH, Herford, 
Germany).  Intra- and inter-assay of coefficients of variation were 2.8% and 2.1%, 
respectively, and, least detectable dose was 0.019 ng/mL. 
Plasma glucose concentration was determined using a glucose analyzer 
(GA-1151; Arkray Co, Ltd., Kyoto, Japan).  Plasma beta-hydroxy butyrate (BHBA), 
NEFA, triglyceride (TG), total-cholesterol (T-CHO) and urea nitrogen (UN) 
concentrations were determined using an automated biochemical analyser (Beckman 
Coulter, Inc., CA, USA). 
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3.2.5. Statistics 
Data for feed intake, milk yield and milk composition were analyzed using the 
MIXED procedure of SAS (SAS Institute Inc., Cary, NC, USA).  The mixed model 
included treatment as a fixed effect, and cow and period as random effects.  For the 
statistical analysis of plasma hormone and metabolite concentrations, sampling time 
and sampling time × treatment were added to the model.  Results are expressed as 
least squares means and standard error of means.  Significant differences were set at P 
< 0.05 and trends were set at P < 0.15. 
 
 
3.3. Results and Discussion 
3.3.1. Feed Intake, Milk Yield, Milk Composition and BW Change 
      DMI and MEI were lower in the MCFA-Ca diet-fed cows than in the control 
diet-fed cows (P = 0.006 and P = 0.013, respectively, Table 3-2).  Grummer and 
Socha (1989) reported that medium-chain triglyceride (C8:0 and C10:0) 
supplementation reduced DMI in lactating cows.  Dohme et al. (2004) reported that 
supplementation with lauric acid (C12:0) also reduced DMI in lactating cows.  
Dietary medium-chain fatty acids or triglyceride supplements often reduce DMI likely 
because of the modification of ruminal digestion (Hristov et al., 2009; Reveneau et al., 
2012).  Although rumen-protected fat was used in this study, it might affect ruminal 
fermentation and fiber digestion to reduce DMI.  Kawamura et al. (1990) reported 
that calcium salts of capric acid and lauric acid decreased protozoa concentration in the 
rumen fluid in lactating dairy cows, suggesting the MCFA-Ca might affect ruminal 
fermentation.  In addition, fat supplements can reduce DMI even when they are fed in 
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the rumen-protected form or by abomasal infusion (Sutton et al., 1983; Relling and 
Reynolds, 2008).  Therefore, reduction in DMI may have resulted partly from factors 
other than the adverse effects of fat on ruminal digestion. 
Milk yield tended to be decreased by the MCFA-Ca diet relative to the control 
diet (P = 0.077, Table 3-2).  Milk protein content and yield were decreased by the 
MCFA-Ca diet (P = 0.021 and P = 0.008, respectively, Table 3-2).  Milk lactose 
content and yield were also decreased by the MCFA-Ca diet (P = 0.020 and P = 0.021, 
respectively, Table 3-2).  However, weekly BW changes tended to be higher in 
MCFA-Ca diet-fed cows (P = 0.119, Table 3-2).  In beef heifers, feeding refined 
coconut oil (rich in MCFA) increased average daily gain and gain efficiency, although 
DMI and gross energy intake were unaffected (Jordan et al., 2006).  On the other 
hand, retained energy tended to be decreased by the MCFA-Ca diet (P = 0.080, Table 
3-2).  This result probably reflected that 4% FCM did not change in spite of the 
reduction of energy intake in the MCFA-Ca diet-fed cows.  It is controversial whether 
MCFA-Ca supplementation preferentially distributes the ingested energy to body 
accumulation or milk production.  MCFA, especially lauric acid, exhibit potent 
antiprotozoal properties and reduce ruminal methane production (Dohme et al., 1999, 
2001), suggesting MCFA can avoid an energy loss from the methane emission.  
Therefore, actual MEI and retained energy may be underestimated because using 
calcium salts of long-chain fatty acids as substitute for MCFA-Ca.  A proper 
examination that determines MEI or NEintake in MCFA-Ca diet-fed cows should be 
done. 
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3.3.2. Responses of Hormones and Metabolites to Diets 
     Plasma ghrelin, GH, GLP-1, insulin, glucose, BHBA, NEFA, TG, T-CHO and 
UN concentrations varied over time (P < 0.05, Figure 3-1, 3-2).  No significant 
interactions of time and treatment were observed.  Plasma ghrelin, glucose, GH and 
NEFA concentrations decreased postprandially, whereas plasma GLP-1, insulin, BHBA, 
TG, T-CHO and UN concentrations increased after feeding. 
 
3.3.3. Plasma Hormone concentrations 
The MCFA-Ca diet resulted in an increase in plasma ghrelin concentrations 
relative to the control diet (P = 0.021, Table 3-3).  Ghrelin is produced by 
gastrointestinal ghrelin cells.  Its unique characteristic is that it requires acylation with 
n-octanoate (C8:0) at its Ser3 residue in order to become a proper ligand for its only 
known receptor, that is the growth hormone secretagogue receptor 1a (GHS-R1a) 
(Nakazato et al., 2001).  In rats, MCFA ingestion increased stomach octanoyl ghrelin, 
whereas the amount of total ghrelin was unchanged in rats (Nishi et al., 2005).  
Kirchner et al. (2009) also showed an increase of more than double the concentration 
of octanoyl ghrelin in mice fed a medium-chain triglyceride-enriched diet.  These 
studies suggested that dietary MCFA are used directly in ghrelin acylation, thereby 
affecting circulating ghrelin concentration.  The acylated active form of ghrelin was 
determined in this assay (Sugino et al., 2004); therefore, the increase in plasma 
acylated ghrelin concentrations by MCFA-Ca supplementation in our study may have 
been caused by an increase in MCFA supply. 
Plasma ghrelin concentration was higher in the MCFA-Ca diet-fed cows, but 
plasma GH concentration was not different between the treatments (Table 3-3).  In 
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addition, MCFA-Ca diet induced a decrease in plasma IGF-1 concentration (P < 0.001, 
Table 3-3).  High-protein diets or higher energy intake increases plasma IGF-1 
concentration (Fontana et al., 2008).  Therefore, in this study, the decrease in plasma 
IGF-1 of MCFA-Ca diet-fed cows might be caused by lower energy and CP intake.  
In this study, milk yield decreased in MCFA-Ca diet fed cows might be contributed by 
the lower IGF-1 concentration. 
GLP-1 was produced by L cells mainly in the small intestine and secreted in 
response to carbohydrates and lipids.  Several studies reported that dietary LCFAs 
increased plasma GLP-1 concentrations in cows (Litherland et al., 2005; Relling and 
Reynolds, 2007, 2008).  However, in this study, no change in plasma GLP-1 
concentrations was noted in the MCFA-Ca diet-fed cows compared with the control 
diet-fed cows (Table 3-3).  Although the mechanisms regulating fat-stimulated GLP-1 
release have not been clarified in detail, Beglinger et al. (2010) reported that 
intraduodenal infusion of sodium caprylate did not stimulate GLP-1 release but that 
sodium oleate was effective in humans.  On the other hand, Hirasawa et al. (2005) 
demonstrated that the stimulation of G protein-coupled receptor 120 (GPR120), a 
receptor for unsaturated LCFA, promoted GLP-1 secretion in vitro and in vivo in mice.  
Therefore, MCFA might not directly induce GLP-1 release because they are not the 
ligands of GPR120. 
Ghrelin and GLP-1 are known to have a function in food intake regulation.  
Ghrelin enhances food intake and GLP-1 decreases food intake in non-ruminants and 
ruminants (Gutzwiller et al., 1999; Nakazato et al., 2001; Harrison et al., 2008; Relling 
et al., 2011; Wertz-Lutz et al., 2006).  As a result, no adverse effect of gut hormones 
on reduction in DMI was found in the MCFA-Ca diet-fed cows in this study.  Thus, 
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reduction in DMI due to MCFA may have been caused by factors other than ghrelin 
and GLP-1.  Higher concentrations of MCFA, bound to albumin, trnsfered to the liver 
through the portal blood and are rapidly oxidized by the liver compared with LCFAs 
because MCFA do not require transformation by carnitine palmitoyl transferase I to 
penetrate the mitochondria (Bach and Babayan, 1982).  Reduction in DMI by MCFA 
may be attributable to increased oxidation of MCFA in the liver (Allen et al., 2009). 
Plasma insulin concentration was lower (P < 0.001, Table 3-3) in the MCFA-Ca 
diet-fed cows than in the control diet-fed cows, whereas no difference in plasma 
glucagon concentrations was observed (Table 3-3).  Although lower levels of 
insulinemia due to MCFA supplementation were shown in the report by Piot et al. 
(1999), other studies in rats (Turner et al., 2009; Wein et al., 2009) and calves (Mills et 
al., 2010) observed no change in plasma insulin concentrations.  Thus, MCFA by 
itself may not have affected insulin release.  Dohme et al. (1999) reported that 
coconut oil adversely affected fiber degradation in the rumen.  The result suggests 
that VFA absorption might be lower in the MCFA-Ca.  Although rumen or plasma 
VFA concentration was not determined in this study, the decreases in plasma GLP-1 
and insulin concentrations might been caused by lower VFA absorption in the 
MCFA-Ca diet-fed cows. 
 
3.3.4. Plasma metabolite concentrations 
In this study, various changes in plasma metabolites were observed with 
MCFA-Ca supplementation.  MCFA-Ca diet induced increases in plasma BHBA, 
NEFA, T-CHO, and UN concentrations (P ≤ 0.001, Table 3-3).  Plasma glucose 
concentration was lower in the MCFA-Ca diet-fed cows than in the control diet-fed 
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cows (P = 0.011, Table 3-3).  The increase in plasma NEFA concentration induced by 
MCFA was consistent with previous findings (Keller et al., 2002; Mills et al., 2010).  
The increase in plasma BHBA concentrations may have occurred because of rapid 
MCFA oxidation as demonstrated in previous studies (Dias et al., 1990; Shinohara et 
al., 2005).  The higher plasma T-CHO concentration may be caused by the higher 
β-oxidation of MCFA-Ca because cholesterol is made from acetyl-CoA.  The 
previous study observed a decrease in DMI-enhanced urea production (Obitsu et al., 
2011).  In addition, MCFA reduced protozoa to decrease ruminal ammonia (Dohme et 
al., 1999, 2001), suggesting that a paucity of ammonia is necessary for urea production 
in order to enhance Gln catabolism (Nieto et al., 2002).  This hypothesis accords with 
the higher plasma UN concentrations in the MCFA diet-fed cows in this study.  A 
correlation between the rate of β-oxidation of MCFA-Ca in the liver and muscle, and 
increased glucose sensitivity has been demonstrated by insulin challenge (Han et al., 
2003; Perdomo et al., 2004).  This insulin-stimulated decrease in plasma glucose 
concentration was greater in the MCFA diet-fed calves (Mills et al., 2010).  Although 
the insulin response was not directly measured in this study, the decrease in plasma 
glucose concentration and milk lactose content and yield may have been partly due to 
enhanced insulin action.  Alternatively, ketone bodies could decrease lactate removal 
and glucose production in hepatocytes (Kummel, 1984), which may be responsible for 
the lower plasma glucose concentrations and milk lactose yield in this study. 
 
3.3.5. The effect of MCFA on ghrelin-induced increases of plasma hormone and 
metabolite concentrations 
     Because MCFA-Ca diet affected basal values of these plasma concentrations, 
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incremental areas, expressed by deducting from AUC for the pre-injection areas, were 
used for the comparisons.  Incremental areas of plasma hormone (GH, glucagon, and 
insulin) and metabolite (glucose and NEFA) concentrations are presented in Table 3-4.  
As previous reports described (Itoh et al., 2006; Roche et al., 2008), ghrelin injection 
also increases plasma pancreatic hormone, glucose and NEFA concentrations during 
lactating period.  Furthermore, in Chapter 2, amino acid infusion enhanced 
ghrelin-induced insulin and glucagon secretion and glucose uptake.  In the current 
study, there were no differences between treatments in incremental areas of plasma GH, 
glucagon, insulin, and glucose concentrations.  The incremental area of NEFA from 
60 to 120 min in MCFA-Ca diet-fed cows tended to be greater compared with control 
diet-fed cows (P = 0.091, Table 3-4).  However, overall, there were little effects of 
MCFA on ghrelin action which increases plasma hormone and metabolite 
concentrations. 
 
3.3.6. Conclusion 
In the present experiment, the effect of MCFA on lactating dairy cows was 
examined with a focus on changes in plasma ghrelin, GH, the other hormone and 
metabolite concentrations, ghrelin action, and their relationship with milk production.  
The observations suggested that MCFA-Ca supplementation might increase plasma 
ghrelin concentration although it might not contribute to higher plasma GH and IGF-1 
concentrations.  MCFA-Ca supplementation indicated the possibility to increase 
production efficiency, but milk yield was not increased probably because of the 
decrease in DMI.  A reduction in DMI due to MCFA-Ca supplementation remains an 
unsolved problem.  Therefore, improving the adverse effects of MCFA on feed intake 
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is an important subject.  In addition, many researchers have pointed out that MCFA 
supplementation induces liver lipidosis in rodents (Turner et al., 2009; Wein et al., 
2009) and calves (Piot et al., 1999; Graulet et al., 2000; Mills et al., 2010).  The use 
of MCFA-Ca for dietary supplementation in lactating dairy cows requires further 
research.  
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Item Control MCFA-Ca1
Ingredient (% DM basis)
     Corn silage             40.0            39.4
     Alfalfa hay cubes               8.3              8.1
     Sudan grass hay               5.1              5.0
     Mixed concentrate2             32.7            32.3
     Soybean meal               5.6              5.5
     Beet pulp pellet               8.3              8.2
     Calcium salts of fatty acids 3               0.0              1.5
Chemical composition (DM basis)
     OM4 (%)             93.1            92.9
     CP5 (%)             16.1            16.0
     NDF6 (%)             39.5            39.0
     EE7 (%)               2.7              3.9
     ME8 (Mcal/kg)               2.6              2.7
55% lauric acid.
8ME = Metabolizable energy: Estimated value from NRC (2001).
3Star mate: Declared fatty acids contained 25% caprylic acid, 20% capric acid,
4OM = organic matter.
5CP = crude protein.
6NDF = neutral detergent fiber.
7EE = ether extract.
Table 3-1. Ingredient and chemical composition of the diets
Treatment
1MCFA-Ca = calcium salts of medium-chain fatty acids.
2Mixed concentrate contained 55% corn grain, 20% corn gluten feed,
10% soybean meal, 7% canola meal, 8% others (wheat middlings, wheat bran, 
molasses, calcium carbonate, salt, and vitamin premix).
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Table 3-2. Feed intake, milk production and composition during experimental period in lactating cows
Item         Control      MCFA-Ca1      SEM    P- value
DMI2 (kg/d)           22.2         19.5      0.733     0.006
MEI3 (Mcal/day)           57.7         52.0      1.94     0.013
Milk yield (kg/d)           28.4         27.5      2.50     0.077
4% FCM (kg/d)4           28.0         26.2      0.149     0.149
Milk composition (%)
Fat             3.93           3.75      0.213     0.357
Protein             3.27           3.15      0.145     0.021
Lactose             4.34           4.23      0.057     0.020
TS5           12.5         12.2      0.305     0.131
SNF6             8.59           8.38      0.120     0.004
Milk composition yield (kg/d)
Fat             1.10           1.00      0.094     0.246
Protein             0.915           0.854      0.056     0.008
Lactose             1.24           1.16      0.115     0.021
Body weight changes (kg/week)            -0.695           8.79      6.76     0.119
Retained energy (Mcal/d)             6.19           3.78      1.26     0.080
2DMI = dry matter intake.
3MEI = metabolizable energy intake.
5TS = total solid.
6SNF = solid not fat.
44% FCM (kg/d) = 4% fat correct milk = 0.4 × Milk yield (kg/d) + 15 ×Milk yield (kg/d) × Milk fat (%).
Data are shown by least squares means (LSM) and standard errors of the LSM (SEM).
Treatment
1MCFA-Ca = calcium salts of medium-chain fatty acids.
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Table 3-3. Plasma hormone and metabolite concentrations during feeding period in lactating cows
Item   Control MCFA-Ca1    SEM    Time Treatment
Treatment
× Time
Hormones (ng/mL)
    Ghrelin     0.129     0.185    0.045 <0.001    0.021    0.903
    GH2   33.1   40.1  12.9 <0.001    0.216    0.986
    IGF-13   70.2   62.7  13.5   0.947  <0.001    0.940
    GLP-14     1.00     1.01    0.342   0.012    0.174    0.309
    Glucagon     0.353     0.332    0.058   0.640    0.118    0.245
    Insulin     5.06     3.76    0.82 <0.001  <0.001    0.131
Metabolites
    Glucose (mg/dL)   68.9   67.5    2.01 <0.001    0.011    0.203
    BHBA5 (μmol/L) 407 507  50.5 <0.001  <0.001    0.888
    NEFA6 (μEq/L)   85.1 106    6.87 <0.001  <0.001    0.597
    TG7 (mg/dL)     7.25     7.26    0.394 <0.001    0.509    0.758
    T-CHO8 (mg/dL) 167 190  15.1 <0.001    0.001    0.889
    UN9 (mgN/dL)   15.7   16.7    0.949 <0.001  <0.001    0.999
2GH = growth hormone.
3IGF-1 = insulin-like growth factor-1.
4GLP-1 = glucagon-like peptide-1 (7-36) amide.
5BHBA = beta-hydroxy butyrate.
6NEFA = non-esterified fatty acids.
7TG = triglyceride.
8T-CHO = total-cholesterol.
9UN = urea nitrogen.
Treatment P -value
Data are shown by least squares means (LSM) and standard errors of the LSM (SEM).
1MCFA-Ca = calcium salts of medium-chain fatty acids.
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Control MCFA-Ca1 SEM P  value
  GH2 (ng/mL･min)
0 - 60     43.4     52.2      24.66       0.278
60 - 120       2.14       4.22        2.75       0.629
  Glucagon (pg/mL･min)   
0 - 60       0.0583       0.0270        0.0144       0.132
60 - 120       0.0754       0.0135        0.0274       0.197
  Insulin (ng/mL･min)
0 - 60       1.76       2.95        1.03       0.146
60 - 120       1.66       0.698        0.730       0.336
  Glucose (mg/dL･min)
0 - 60       5.84       3.88       1.32       0.251
60 - 120     12.1       2.41       4.73       0.207
  NEFA3 (μEq/L･min)
0 - 60     22.8     36.6       7.57       0.198
60 - 120     27.6       8.67       8.57       0.091
Data are shown by least squares means (LSM) and standard errors of the LSM (SEM).
1MCFA-Ca = calcium salts of medium-chain fatty acids.
2GH = growth hormone.
3NEFA = non-esterified fatty acids.
Item
Treatment
Table 3-4. Incremental areas of plasma hormone and metabolite concentrations by
intravenous ghrelin injection
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Figure 3-1 
 
Plasma hormone (ghrelin: A, GH: B, IGF-1: C, GLP-1: D, Insulin: E and Glucagon: F) 
concentrations in cows fed control diet (○with a solid line) and MCFA-Ca (● with a doted line). 
Values are expressed as least square of means (n = 5).  The horizontal bar and arrow show the 
milking period and feeding time, respectively. 
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Figure 3-2 
 
Plasma metabolite (glucose: A, BHBA: B, NEFA: C, TG: D, T-CHO: E and UN: F) concentrations 
in cows fed control diet (○with a solid line) and MCFA-Ca (● with a doted line).  Values are 
expressed as least square of means (n = 5).  The horizontal bar and arrow show the milking period 
and feeding time, respectively. 
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Chapter 4 
 
 
Effects of Feeding Long-Chain Fatty Acids and Rumen-Protected 
Methionine on Plasma Ghrelin Concentration and Milk Production 
 in Lactating Dairy Cows 
 
4.1. Introduction 
In Chapter 3, MCFA diet could increase plasma ghrelin concentration.  
However, higher plasma ghrelin concentration did not contribute to higher GH 
concentration and milk production.  Fat supplementation derived from long-chain 
fatty acids is valid to increase dietary energy density (NRC, 2001).  However, 
increasing the dietary fat content often depresses DMI of lactating cows (Allen, 2000).  
The mechanism of hypophagia induced by fat supplementation is incompletely 
understood and assumed to be affected by various factors involving the absorption 
process and metabolism of fatty acids.  Methionine (Met) improves lipid metabolism 
(Yagasaki et al., 1989) partially by altering the activities of hormone-sensitive lipase 
and lipoprotein lipase (Kawasaki et al., 2010).  In dairy cows, Met is the first limiting 
amino acid for milk production (Schwab et al., 1976).  Supplementation of Met 
hydroxyl analog increases milk fat synthesis with hypertriglycemia (Huber et al., 1984).  
Conversely, an insufficiency of Met during the periparturient period results in the 
development of hepatic lipidosis (Shibano and Kawamura, 2005).  These reports 
suggest that Met may affect lipid metabolism in dairy cows.  In lactating ewes, 
supplementation of rumen-protected Met (RPM) combined with fat increased DMI, 
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milk yield and milk fat secretion compared with the supplementation of fat only 
(Goulas et al., 2003), but the effects of Met on secretions of ghrelin and other 
metabolic hormones were unknown.  Therefore, the effects of adding calcium salts of 
long-chain fatty acids (LCFA-Ca) and RPM on plasma ghrelin, GH and other hormone 
concentrations and milk production in lactating cows were investigated in this study.   
 
 
4.2. Materials and Methods 
The procedures used in the present study were carried out in accordance with the 
principles and guidelines for animal use issued by the National Institute of Livestock 
and Grassland Science Animal Care Committee, and which were formulated to comply 
with Japanese regulations. 
 
4.2.1. Animals and Management  
Four lactating Holstein cows [calving number: 1.75 ± 0.25 (primiparous: n = 1, 
multiparous: n = 3), initial DIM: 143.5 ± 3.9, initial BW: 547.3 ± 14.7 kg] were fed 
four diets formulated to meet the nutrient requirements according to the Japanese 
Feeding Standard for Dairy Cattle (2006).  The ingredients and composition of the 
diets are presented in Table 4-1.  The cows were managed in individual tie stalls, 
allowed free access to water, and provided experimental diets twice daily at 0900 and 
1800 h.  They were milked twice daily before each feeding (0840 and 1740 h), and 
weighed every week.  
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4.2.2. Treatments and Experimental Design 
The cows were used in a 4 × 4 Latin square design in each 2 week period.  Four 
treatments consist of basal diet only (without supplement), supplemented with 
LCFA-Ca made from palm and soybean oil [Megalac R (Church & Dwight Co., Inc., 
Princeton, NJ, USA)], with RPM [Lactet SP (Nippon Soda Co., Ltd., Tokyo, Japan)], 
and with LCFA-Ca plus RPM.  The LCFA-Ca containing 85% fatty acids was added 
to 1.5% of the diet DM, following a previous study (Bilby et al., 2006).  The RPM 
containing 67% of DL-Met was supplemented at 20 g/d for RPM or LCFA-Ca plus 
RPM treatment.  Cows were offered each diet ad libitum, allowing for 15% refusal 
for the first 10 d for each treatment.  For the last 4 d of each period, the cows were fed 
95% of ad libitum intake.  Refusals were weighed daily before each morning feeding 
(0800 h). 
 
4.2.3. Sampling 
     Samples of the diets and the refusals were collected and pooled for the last 4 d of 
each period.  Milk samples were collected for the last 4 d of each period, added with 
sodium azide as preservative, and stored at 4°C until analysis.  Blood samples were 
taken at 12 d from the jugular vein catheter inserted on 10 d of each period.  Blood 
samples (8 mL) were taken at 10 min intervals from 0800 to 1100 h.  Blood samples 
were collected into heparinized tubes with aprotinin (500 KIU/mL of blood) and 
centrifuged at 1,500 × g for 20 min at 4°C.  Harvested plasma samples were stored 
at -80°C until assay. 
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4.2.4. Sample Analysis 
     The diet samples, refusals and milk samples were analysed as described at 
Chapter 3.2.4.  Plasma ghrelin, GH, IGF-1, GLP-1, insulin and glucose 
concentrations were determined every 10 min and plasma glucagon, BHBA, NEFA, 
TG, T-CHO and UN concentrations were determined every 20 min.  Plasma amino 
acid concentrations were measured at 0900h.  Assays of plasma ghrelin, GH, 
glucagon and insulin concentrations were conducted as described at Chapter 2.2.4.  
Plasma IGF-1, GLP-1, glucose, BHBA, NEFA, TG, T-CHO and UN concentrations 
were determined as described at Chapter 3.2.4.  Plasma amino acid concentrations 
were determined by ion-exchange chromatography using an automatic amino acid 
analyzer (JLC-500; JEOL Ltd., Tokyo, Japan) after deproteinization of plasma with an 
equal volume of sulfosalicylic acid (3% wt/vol). 
 
4.2.5. Statistics 
Data for feed intake, milk yield and milk composition were analyzed using the 
MIXED procedure of SAS (SAS Institute, Inc., Cary, NC, USA).  The mixed model 
included treatment as a fixed effect, and cow and period as random effects.  For the 
statistical analysis of plasma hormone and metabolite concentration, sampling time and 
sampling time × treatment were added to the model.  A 2 × 2 factorial design was 
used to test the main effects of LCFA-CA supplementation (LCFA-Ca vs. 
non-LCFA-Ca), RPM supplementation (RPM vs. non-RPM), and their interaction.  
Results are reported as least squares means and SEM.  Significant differences were 
set at P < 0.05 and trends were set at P < 0.15. 
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4.3. Results and Discussion 
4.3.1. Feed Intake, Milk Yield and Milk Composition 
     DMI in cows fed LCFA-Ca diets compared with cows fed non-LCFA-Ca diets 
was lower (P = 0.025, Table 4-2), whereas MEI was not affected.  Generally, high fat 
inclusion in diets reduces fiber digestion, increases fatty acid absorption, inhibits 
abomasal motility (Nicholson and Omer, 1983) and increases gut hormone secretion 
(Choi et al., 2000; Relling and Reynolds, 2007).  All of these factors would reduce 
DMI.  Supplementation of LCFA-Ca had been expected to alleviate such negative 
effects on ruminal fermentation and fiber digestibility in lactating cows (Schauff and 
Clark, 1989; Schneider et al., 1988).  However, DMI was decreased by LCFA-Ca in 
this study consistent with other reports (Choi and Palmquist, 1996; Schauff and Clark, 
1992).  RPM did not improve suppression of DMI by LCFA-Ca contrary to results 
found by Goulas et al. (2003) who observed feeding fat with RPM increased DMI in 
lactating ewes.  Additionally, Chillard and Doreau (1997) observed no improvement 
effect of RPM on DMI of cows fed a fish oil supplemented diet during mid-lactation, 
although such non-protected fat including high polyunsaturated fatty acids could 
largely inhibit dietary fiber digestion and depress DMI. 
Milk yield and composition, except for total solid contents, were unaffected by 
LCFA-Ca and RPM.  Milk total solid contents tended to be lower in cows fed 
LCFA-Ca diets compared with cows fed non-LCFA-Ca diets (P = 0.107).  In lactating 
ewes, supplementation of RPM combined with fat increased milk yield and milk fat 
secretion compared with the supplementation of fat only (Goulas et al., 2003).  In 
their report, such an increase in milk production was accompanied with higher feed 
intake.  In the present study, DMI or MEI did not increase in combination of 
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LCFA-Ca and RPM. 
 
4.3.2. Responses of Hormones and Metabolites to Diets 
     Plasma ghrelin, insulin, glucose, BHBA, NEFA, TG and UN (except for 
non-LCFA-Ca + RPM) concentrations varied largely through time (P < 0.002, Figures 
4-1, 4-2), and no significance of the interaction time by treatment was observed (P > 
0.192, Figures 4-1, 4-2).  The time effect for plasma ghrelin, glucose and NEFA 
concentrations was due to a postprandial decrease.  Plasma insulin, BHBA, TG and 
UN concentrations increased after feeding. 
 
4.3.3. Plasma Hormone Concentrations 
Plasma ghrelin was higher (P < 0.001, Table 4-3) and plasma GH concentration 
tended to higher (P = 0.054, Table 4-3) in cows fed LCFA-Ca compared with cows not 
fed LCFA-Ca.  Compared with cows fed non-LCFA-Ca, plasma IGF-1, glucagon and 
insulin concentrations in cows fed LCFA-Ca were lower (P < 0.001, P = 0.002, and P 
= 0.012, respectively, Table 4-3), and plasma GLP-1 concentration tended to be lower 
(P = 0.061, Table 4-3).  Plasma IGF-1 concentration was lower (P = 0.017, Table 4-3) 
and plasma insulin concentration tended to be higher (P = 0.092, Table 4-3) in cows 
supplemented RPM than those without RPM.  There were interactions between 
LCFA-Ca and RPM for ghrelin and glucagon (P = 0.002 and P = 0.041, respectively, 
Table 4-3): LCFA-Ca plus RPM increased plasma ghrelin, glucagon, but RPM alone 
did not show such effects.  There tended to be an interaction between LCFA-Ca and 
RPM for GH (P = 0.130, Table 4-3): Plasma GH concentration showed the highest 
level in LCFA-Ca plus RPM.   
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The increase in plasma ghrelin concentration of cows fed LCFA-Ca is consistent 
with that of rats that ingested some fatty acids (Nishi et al., 2005).  In addition, RPM 
decreased plasma ghrelin concentration in cows not fed LCFA-Ca, whereas LCFA-Ca 
plus RPM compared with LCFA-Ca alone increased plasma ghrelin concentration.  
Thus, only a simultaneous inclusion of LCFA-Ca and RPM may enhance ghrelin 
secretion via the changes in lipid metabolism.  Ghrelin enhances feed intake in both 
nonruminants (Nakazato et al., 2001) and ruminants (Harrison et al., 2008; Wertz-Lutz 
et al., 2006).  As a result, we could not find the relationship between plasma ghrelin 
concentration and feed intake in this study.  Since reports on ghrelin responses to lipid 
metabolism in ruminants are limited, further research is desirable. 
Many researchers have reported that high fat supplementation increased GLP-1 
concentration (Benson and Reynolds, 2001; Bradford et al., 2008; Litherland et al., 
2005; Relling and Reynolds, 2007).  Litherland et al. (2005) demonstrated that 
abomasal infusion of fat increased plasma GLP-1 concentration dependent on dosage.  
Compared with others, the decrease of plasma GLP-1 concentration with LCFA-Ca in 
this study could be attributed to a fewer fat ingestion level of 280 g/d.  GLP-1 plays a 
role in food intake (Turton et al., 1995) and Relling and Reynolds (2007) have reported 
that dietary fats increased GLP-1 in dairy cows.  Additionally, Relling et al. (2011) 
observed that intrajugular infusion of GLP-1 tended to decrease DMI in growing 
wethers.  In this study, however, plasma GLP-1 concentration was decreased by 
LCFA-Ca, suggesting that GLP-1 did not mediate DMI. 
Plasma insulin concentration decreased in cows fed LCFA-Ca with decreasing 
DMI consistent with previous reports (Choi and Palmquist, 1996; Cummins and Sartin, 
1987).  The depression of plasma insulin concentration might be due to a lower VFA 
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production caused by decreased DMI.  Lower plasma BHBA concentration in cows 
fed LCFA-Ca was possibly caused by less butyrate absorption by depressed ruminal 
fermentation.  And, plasma GLP-1 concentration in cows fed LCFA-Ca tended to 
decrease at the same time, suggesting decreased GLP-1 may be related to insulin 
depression. 
LCFA-Ca also decreased plasma glucagon concentration.  The result is 
consistent with that of Cummins and Sartin (1987), but inconsistent with that of 
Khorasani and Kennelly (1998).  In several species, elevated NEFA decreases plasma 
glucagon concentration (Gerich et al., 1976; Lavau et al., 1979).  However, the 
present results showed that the decrease of plasma glucagon with LCFA-Ca was 
attenuated by RPM.  In Chapter 2, glucagon secretion was more strongly enhanced 
when amino acids and ghrelin were simultaneously administered in comparison with 
the administration of ghrelin alone in lactating cows.  Therefore, the combination of 
increase in available Met and higher plasma ghrelin concentration likely increased 
plasma glucagon concentration in LCFA-Ca fed cows.   
 
4.3.4. Plasma Metabolite Concentrations 
Compared to the diets without LCFA-Ca, plasma NEFA, TG, T-CHO and UN 
concentrations in cows fed LCFA-Ca were higher (P < 0.001, P = 0.029, P < 0.001, 
and P < 0.001, respectively, Table 4-3), but with lower plasma BHBA concentration (P 
= 0.006, Table 4-3).  In cows fed RPM diets, plasma glucose concentration was 
higher (P = 0.001, Table 4-3), plasma T-CHO concentration was lower (P = 0.009, 
Table 4-3), and plasma NEFA and UN concentration tended to be lower (P = 0.15 and 
P = 0.121, respectively, Table 4-3).  Interactions between LCFA-Ca and RPM were 
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observed for TG and T-CHO (P = 0.049 and P = 0.003, respectively, Table 4-3): RPM 
decreased plasma TG and T-CHO concentrations in cows fed LCFA-Ca, but did not 
affect the cows not fed with LCFA-Ca.  In cows fed RPM diets, plasma Met 
concentration tended to be higher (P = 0.101, Table 4-4).  There was an interaction 
between LCFA-Ca and RPM for Met (P = 0.096, Table 4-4): RPM alone increased 
plasma Met concentration, but LCFA-Ca plus RPM decreased. 
The increase in plasma glucose concentration of cows fed RPM was consistent 
with Berthiaume et al. (2001), while inconsistent with Bertics and Grummer (1999).  
Such discrepancies might be explained by the differences in the physiological state of 
cows: the present study and the study by Berthiaume et al. (2001) used mid-lactating 
cows, but the study by Bartics and Grummer used early-lactating cows. 
Plasma NEFA, T-CHO and TG concentrations increased by LCFA-Ca in the 
current study has been previously observed in cows (Choi et al., 2000; Gobert et al., 
2009).  On the other hand, RPM with LCFA-Ca decreased plasma T-CHO and TG 
concentrations, and tended to decrease plasma NEFA concentration (Table 4-3).  Met 
is a methyl group donor for phosphatidylcholine in dairy cows (Pinotti et al., 2002) to 
enhance plasma lipoprotein.  In laboratory animals, casein (a Met-rich protein) or 
L-Met induced hypercholesterolemia in rabbits and rats (Khosla et al., 1989; Oda et al., 
1991).  In calves, however, a high fat diet supplemented with L-Met did not increase 
plasma VLDL concentration (Auboiron et al., 1993), and Met hydroxyl analog did not 
affect hepatic TG accumulation in cows (Bertics and Grummer, 1999).  Whether Met 
enhanced VLDL that was not measured in this study is unknown.  On the other hand, 
because Met is converted to taurine in dairy cows, plasma taurine concentration 
increased linearly with an increase of postruminal Met infusion (Pisulewski et al., 
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1996).  Taurine conjugates with bile acids to become taurocholate in the liver, and 
promotes lipid absorption and cholesterol consumption (Yokogoshi and Oda, 2002).  
Yagasaki et al. (1989) showed that dietary Met and glycine reduced serum T-CHO and 
increased fecal sterol excretion in rats.  Furthermore, Met as a sulfur amino acid 
suppressed serum NEFA and TG concentration through the control of 
hormone-sensitive lipase activity and the restoration of lipoprotein lipase activity in 
peripheral tissues of hepatoma-bearing rats (Kawasaki et al., 2010).  In this study, 
therefore, suppression of plasma T-CHO, NEFA and TG with LCFA-Ca plus Met might 
be induced by enhanced uptake and use of lipids by various tissues. 
Berthiaume et al (2001, 2006) reported that feeding RPM clearly increased 
arterial Met concentration.  However, in this study, plasma Met concentration did not 
clearly increased because of the peripheral venous value.  Ingested RPM was likely 
taken up by the peripheral tissues.   
 
4.3.5. Conclusion 
The present study did not show any favorable effects of RPM on feed intake and 
milk production in cows fed with LCFA-Ca, although plasma ghrelin concentration 
increased.  Further studies are desirable to elucidate the effects of lactating stage and 
Met supplemental level with LCFA-Ca on DMI and milk production. 
In conclusion, the responses to LCFA-Ca are associated with the increases in 
plasma concentration of ghrelin and the decreases of insulin, glucagon and GLP-1.  
RPM plus LCFA-Ca modulated plasma lipid concentrations and concomitantly 
elevated plasma ghrelin concentration.  These metabolic and endocrine changes may 
be induced by absorbed LCFA and Met, but the increase in plasma ghrelin 
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concentration did not involve with MEI or an increase in milk production. 
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Item non-LCFA-Ca LCFA-Ca1
Ingredient (% DM basis)
     Corn silage       42.2       41.6
     Alfalfa hay cubes         7.2         7.1
     Sudan grass hay         5.7         5.6
     Mixed concentrate2       37.8       37.2
     Beet pulp pellets         7.1         7.0
     Calcium salts of fatty acids3         0.0         1.5
Chemical composition (DM basis)
     OM4 (%)       93.0       92.7
     CP5 (%)       14.1       13.9
     NDF6 (%)       32.2       31.7
    EE7 (%)         3.2         4.5
     ME8 (Mcal/kg)         2.4         2.5
wheat bran, molasses, calcium carbonate, salt and vitamin premix).
4OM = organic matter.
5CP = crude protein.
6NDF = neutral detergent fiber.
7EE = ether extract.
stearic acid, 33% oleic acid, 32% linoleic acid and 5% linolenic acid.
8ME = Metabolizable energy: Estimated value from NRC (2001).
Table 4-1. Ingredient and chemical composition of the diets
1LCFA-Ca = calcium salts of long-chain fatty acids.
2Mixed concentrate contained 55% corn grain, 20% corn gluten feed,
10% soybean meal, 7% canola meal and 8% others (wheat middlings, 
3Megalac R: Declared fatty acids contained 26% palmitic acid, 4%
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Table 4-2. Feed intake, milk production and composition during experimental period in lactating cows
Item non-RPM RPM non-RPM   RPM2 SEM LCFA-Ca  RPM LCFA × RPM
DMI4 (kg/d) 22.4 22.2 21.3 21.7   0.675 0.025 0.803 0.322
MEI5 (Mcal/d) 56.7 56.2 55.4 56.4 1.72 0.463 0.794 0.325
Milk yield (kg/d) 27.2 27.1 27.3 27.5 1.83 0.508 0.982 0.655
4% FCM6 (kg/d) 29.9 28.8 30.0 30.3 1.63 0.505 0.766 0.574
Milk composition (%)
Fat    4.46    4.35    4.48    4.42 0.44 0.825 0.685 0.909
Protein    3.51    3.56    3.47    3.45   0.132 0.177 0.729 0.508
Lactose    4.62    4.59    4.61    4.61   0.059 0.736 0.743 0.662
TS7 13.6 13.5 12.7 12.5 1.01 0.107 0.759 0.966
SNF8    9.13    9.11    9.08    9.11   0.124 0.736 0.973 0.710
Milk composition yield (kg/d)
    Fat       1.19       1.16       1.20       1.21      0.062     0.772     0.369        0.558
    Protein       0.950       0.957       0.942       0.947      0.037     0.517     0.302        0.954
    Lactate       1.26       1.24       1.26       1.27      0.089     0.870     0.316        0.139
Body weight changes (kg/week)     14.3     18.5     13.5     12.7 4.60 0.359 0.612 0.474
Retained energy (Mcal/d)       3.98       3.22       3.44       3.22   0.986 0.437 0.990 0.440
4DMI = dry matter intake
Treatment
         non-LCFA-Ca                 LCFA-Ca 1          Contrast3 (P -value)
7TS = sotal solid.
8SNF = solid not fat.
64% FCM = 4% fat corrected milk (kg/d) = 0.4 × Milk yield (kg/d) + 15 × Milk yield (kg/d) × Milk fat (%).
Data are shown by least squares means (LSM) and SEM.
1LCFA-Ca = calcium salts of long-chain fatty acids.
2RPM = rumen-protected methionine.
3P -value for factorial contrasts: LCFA-Ca, RPM and the interaction between LCFA-Ca and RPM.
5MEI = metabolizable energy intake.
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Item non-RPM RPM non-RPM   RPM2 SEM LCFA-Ca RPM LCFA × RPM
Hormones (ng/mL)
    Ghrelin      0.106      0.087     0.116      0.126      0.027  <0.001   0.301      0.002
    GH4    14.1    11.2   14.9    17.8      3.55    0.054   0.993      0.130
    IGF-15  107  102   95.5    86.9    31.8  <0.001   0.017      0.649
    GLP-16      0.519      0.464     0.452      0.448      0.128    0.061   0.185      0.258
    Glucagon      0.991      0.936     0.603      0.855      0.462    0.002   0.187      0.041
    Insulin      2.51      2.86     2.36      2.41      0.128    0.012   0.092      0.202
Metabolites
    Glucose (mg/dL)    62.9    63.4    62.1    63.6      1.91    0.872   0.001      0.344
    BHBA7 (μmol/L)  595  579  514  517    43.4    0.006   0.796      0.729
    NEFA8 (μEq/L)    95.4    90.2  116  110      7.13  <0.001   0.150      0.842
    TG9 (mg/dL)      7.57      8.29      9.86      8.41      0.82    0.029   0.501      0.049
    T-CHO10 (mg/dL)  197  200  247  211    14.9  <0.001   0.009      0.003
    UN11 (mgN/dL)      8.79      8.13      9.26      9.23      0.70  <0.001   0.121      0.152
6GLP-1 = glucagon-like peptide-1 (7-36) amide.
Table 4-3. Plasma hormone and metabolite concentrations during feeding period in lactating cows
Treatment
     non-LCFA-Ca     LCFA-Ca1 Contrast3 (P -value)
Data are shown by least squares means (LSM) and SEM.
1LCFA-Ca = calcium salts of long-chain fatty acids.
2RPM = rumen-protected methionine.
3P -value for factorial contrasts: LCFA-Ca, RPM and the interaction between LCFA-Ca and RPM.
8BHBA = beta-hydroxy butyrate.
11UN = urea nitrogen.
9TG = triglyceride.
7NEFA = non-esterified fatty acids.
10T-CHO = total-cholesterol.
4GH = growth hormone.
5IGF-1 = insulin-like growth factor-1.
56 
 
 
 
 
 
 
 
Table 4-4. Plasma amino acid concentrations during experimental period in lactating cows
Item non-RPM RPM non-RPM   RPM2 SEM LCFA-Ca RPM LCFA × RPM
EAA4 (nmol/mL)
    Arginine    60.4    91.7  102    92.5   12.6   0.322   0.081   0.092
    Histidine    30.6    39.5    33.1    27.6     6.51   0.671   0.261   0.105
    Isoleucine  110  134  134  131   15.2   0.487   0.462   0.371
    Leucine  125  145  158  147   20.8   0.710   0.223   0.271
    Lystine    66.4    92.3    95.9    90.7   13.0   0.401   0.270   0.226
    Methionine    25.2    36.1    38.3    36.0     4.03   0.243   0.101   0.096
    Phenylalanine    37.6    43.8    47.8    44.9     6.40   0.713   0.232   0.329
    Threonine    95.5  115  134  109   16.3   0.864   0.320   0.195
    Tryptophan    39.9    41.8    37.3    34.3     3.14   0.851   0.122   0.426
    Valine  229  259  267  252   24.4   0.739   0.506   0.325
NEAA5 (nmol/mL)
    Alanine  296  332  348  324   31.1   0.799   0.356   0.234
    Asparagine    55.5    69.8    78.0    70.7     8.57   0.686   0.202   0.239
    Aspartate      6.11      7.19      8.13      7.14     0.714   0.952   0.216   0.200
    Citrulline    89.0    94.2    99.1    92.1   10.4   0.839   0.403   0.220
    Cystine      1.85      2.31      0.697      1.12     1.01   0.541   0.138   0.979
    Glutamine  273  282  307  267   20.7   0.402   0.603   0.202
    Glutamate    56.9    62.7    61.4    53.2     3.15   0.583   0.273   0.014
    Glycine  449  460  476  449   58.7   0.982   0.563   0.706
    1-methyl histidine      8.72      9.97      8.99      9.04     0.679   0.156   0.441   0.184
    3-methyl histidine      8.01      8.31      7.78      7.34     1.60   0.954   0.618   0.756
    Ornithine    40.5    54.7    54.5    54.6     6.36   0.306   0.316   0.309
    Proline    72.8  104    98.0  100   12.1   0.139   0.314   0.194
    Serine  116    78.8  132    54.8   13.5   0.400   0.747   0.159
    Taurine    33.6    43.9    42.6    42.6     4.99   0.236   0.359   0.232
    Tyrosine    41.5    51.6    59.8    54.4     8.17   0.724   0.149   0.268
Data are shown by least squares means (LSM) and standard errors of the LSM (SEM)
1LCFA-Ca = calcium salts of long-chain fatty acids.
2RPM = rumen-protected methionine.
3P -value for factorial contrasts: LCFA-Ca, RPM and the interaction between LCFA-Ca and RPM.
4EAA: Essential amino acid.
5NEAA: non-essential amino acid.
Contrast3 (P -value)
Treatment
     non-LCFA-Ca     LCFA-Ca1
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Figure 4-1 
 
Plasma hormone (ghrelin: A, GH: B, IGF-1: C, GLP-1: D, glucagon: E and insulin: F) 
concentrations in cows fed each treatment diet: non-LCFA-Ca + non-RPM (○ with a solid line), 
non-LCFA-Ca + RPM (● with a dotted line), LCFA-Ca + non-RPM (△ with a solid line) and 
LCFA-Ca + RPM (▲ with a dotted line).  Values are expressed as least square of means (n = 4).  
P-value for effects of treatment, time and the interaction between treatment and time.  The 
horizontal bar and arrow show the milking period and feeding time, respectively. 
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Figure 4-2 
 
Plasma metabolite (glucose: A, BHBA: B, NEFA: C, TG: D, T-CHO: E and UN: F) concentrations 
in cows fed each treatment diet: non-LCFA-Ca + non-RPM (○ with a solid line), non-LCFA-Ca + 
RPM (● with a dotted line), LCFA-Ca + non-RPM (△ with a solid line) and LCFA-Ca + RPM 
(▲ with a dotted line).  Values are expressed as least square of means (n = 4).  P-value for 
effects of treatment, time and the interaction between treatment and time.  The horizontal bar and 
arrow show the milking period and feeding time, respectively. 
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Chapter 5 
 
 
General Discussion 
 
In recent dairy industry, cows are made to undergo a coordinated series of 
physiological adaptations to support milk synthesis.  This is most noticeable during 
the early lactating period, when the energy demand for milk yield output is greater than 
the ingested energy via feeds.  The energy deficit places cows in a state of negative 
energy balance, resulting in the mobilization of body reserves.  Although GH plays a 
central role in the regulation of nutrient partitioning and key processes for milk 
production, the artificial control of GH secretion and action is very difficult.  Ghrelin, 
one of gastrointestinal hormones, stimulates GH secretion.  In addition, ghrelin is 
related to secretions of other major metabolic hormones (insulin and glucagon), which 
regulate nutrient metabolism in the whole body and involve in milk production.  
Secretions of gastrointestinal hormones are strongly related to ingested nutrients 
(digestion and absorption).  Manipulated ghrelin secretion via feeding management 
may make it possible to modify milk production via the secretions of metabolic 
hormones and metabolic changes.  The present study conducted three experiments 
whith different nutrients (amino acids and fatty acids): the primary aim of this study 
was determine whether available nutrients modify plasma ghrelin concentration.  
Second aim was to determine whether the modification of plasma ghrelin 
concentration by the ingested nutrients affects plasma metabolic hormone 
concentrations and nutrient metabolism, and milk production.  The general summary 
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of these examinations is shown in Table 5-1. 
 
 
5.1. The effects of nutrients on plasma ghrelin concentration 
The previous studies have reported the effects of some nutrients on plasma 
ghrelin concentration using sheep and cattle (Sugino et al., 2010; Fukumori et al., 
2011; Fukumori et al., in press-a).  Among these studies, post-ruminally available 
protein or circulating amino acids may be important factors to regulate ghrelin 
secretion during feeding management (Sugino et al., 2010).  Therefore, the amino 
acid infusion intravenously to lactating cows was conducted in Chapter 2.  As a result, 
the amino acid infusion did not affect plasma ghrelin concentration.  One of the 
possible reasons are those, the infused level of amino acids would be a limiting factor 
because the infusion level was less than the previous studies in sheep (Sugino et al., 
2010; Takahashi et al., 2009), and lactating cows demands more amino acids due to 
lactation.  The previous study by Sugino et al. (2010) and Takahashi et al. (2009) 
loaded numerous amino acids in relative to the individual’s requirement.  Their doses 
of amino acids would be excess as an actual utilization.  Therefore, developing more 
effective way is necessary to increase plasma ghrelin concentration by amino acids.  
The individual amino acid may differentially affect plasma ghrelin concentration.  
Kuhara et al. (1991) demonstrated the varied responses of GH, glucagon and insulin to 
17 kinds of amino acids.  In their report, aspartic acid, glutamic acid, and arginine 
enhanced GH secretion, which may also be consistent with ghrelin secretion.  
Therefore, it is necessary to determine which amino acid possesses a stimulating effect 
on ghrelin secretion. 
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The effect of MCFA on plasma ghrelin concentration was investigated in 
Chapter 3.  As a result, feeding MCFA could increase plasma ghrelin concentration as 
same as the previous report by non-ruminants (Nishi et al., 2005).  The ingested 
MCFA are supposed to be directly used for synthesis of the active-form ghrelin.  
LCFA also increased plasma ghrelin concentration in chapter 4.  LCFA are not used 
for acylation of ghrelin, and therefore, the mechanism how LCFA increases plasma 
ghrelin concentration is unclear.  As one of the possible reasons, changes in lipid 
metabolism might increase plasma ghrelin concentration.  In support to this, the 
accelerated lipid metabolism by LCFA combined with Met augmented ghrelin 
secretion.  It was supposed that Met itself did not enhance ghrelin secretion because 
cows fed Met alone did not increase plasma ghrelin concentration.   
Energy intake level would be one of factors determining plasma ghrelin 
concentration because negative energy balance and feed deprivation increase plasma 
ghrelin concentration (Bradford and Allen, 2008; Wertz-Lutz et al., 2006).  Therefore, 
the possibility that lower MEI in cows by MCFA affected the increases in plasma 
ghrelin concentration cannot be ruled out.  However, our previous study showed that 
the difference in MEI between 100% and 120% of requirement did not affect plasma 
ghrelin concentration (The graduation thesis by Ishizu, 2010), suggesting that the 
variety of energy intake in the positive energy balance may not affect plasma ghrelin 
concentration.  Because all cows used in Chapters 3 and 4 were in the positive energy 
status (Tables 3-2, 4-2), higher plasma ghrelin concentration by MCFA and LCFA plus 
Met treatments was likely due to a difference in available nutrients. 
Overall, obtained results indicate that nutritional treatment may alter plasma 
ghrelin concentration in lactating cows.  Although amino acids did not affect plasma 
62 
 
ghrelin concentration, MCFA, LCFA and LCFA plus Met treatments might be effective 
for increase plasma ghrelin concentration.  Plasma ghrelin concentration when cows 
were fed LCFA and LCFA plus Met showed 9% and 19% rises relative to the 
concentration when they were fed control diet, while MCFA diet showed 43% rises in 
plasma concentration relative to the control diet.  In addition, the previous studies 
determined that VFA (short-chain fatty acids) decrease plasma ghrelin concentration 
(Fukumori et al., 2011; Fukumori et al., in press-a).  These results suggest that the 
differences in carbon chain-length of fatty acids may affect plasma ghrelin 
concentration, and MCFA can largely augment plasma ghrelin concentration.  
 
 
5.2. The effects of nutrients on the responses of metabolic hormones to ghrelin 
injection 
     The past studies demonstrated that ghrelin has characteristic actions in the 
lactating period: the impact of ghrelin on GH secretion was greater in the early 
lactating period compared with other physiological states (Itoh et al., 2005) and the 
ghrelin-induced increases in plasma glucagon, glucose and insulin concentrations were 
observed in the lactating period, but not in other physiological states (Itoh et al., 2006).  
The ghrelin-induced glucagon and glucose releases were shown also in type 2 diabetic 
rats (Adeghate and Parvez, 2002).  Although lactating cows are not in a pathological 
condition, they are thought to be in a state resembling the diabetic state with respect to 
glucose metabolism.  Thus, these results indicate that ghrelin may augment the 
catabolic condition associated with insulin resistance. 
This study determined for the first time the effects of available nutrients on the 
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ghrelin actions.  In Chapter 2, the effects of intravenous amino acids infusion on 
ghrelin induced GH, insulin and glucagon secretions were determined.  As a result, 
the amino acid infusion did not affect the GH response to ghrelin injection, but 
augmented glucagon and insulin releases after ghrelin injection.  Subsequently, the 
amino acid infusion stimulated the recovery of plasma glucose concentration from its 
peak level via augmented insulin release.  This result suggests that amino acids may 
counteract the ghrelin induced catabolic action.  In Chapter 3, the effects of feeding 
MCFA on ghrelin induced GH, insulin and glucagon secretions were determined.  In 
the experiment, although feeding MCFA tended to inhibit the increase in plasma NEFA 
concentration after ghrelin injection, there was not much difference with the control 
diet.  Thus, the amino acid infusion modified the ghrelin action in lactating cows, 
which may contribute to an improvement of insulin sensitivity. 
 
 
5.3. The relationship between ghrelin and metabolic hormones 
     Ghrelin is a GH releasing factor and it is sometimes observed that there is a link 
between plasma ghrelin and GH concentration in the short-term period (pre- and 
post-prandial changes) (Sugino et al., 2002) and the long-term observation (from 
prepartum to lactating period) (Sugino et al., 2006; Bradford and Allen, 2008).  
Therefore, an alteration of plasma ghrelin concentration by nutrients may affect plasma 
GH concentration.  In Chapters 3 and 4, feeding MCFA and LCFA increased plasma 
ghrelin concentration.  The higher plasma ghrelin concentration induced by feeding 
LCFA and LCFA plus Met tended to be accompanied by plasma GH concentration.  
On the other hand, higher ghrelin concentration induced by feeding MCFA did not 
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affect plasma GH concentration although the rise in plasma ghrelin concentration was 
greater in MCFA treatment than LCFA and LCFA plus Met treatments.  Date et al. 
(2000) demonstrated that the continuous administration of ghrelin increased plasma 
GH concentration on d 6 after the continuous administration, but the high plasma GH 
concentration did not last on d 12, suggesting the continuous ghrelin administration 
induced homologous down-regulation of GHS-R.  Therefore, the long-term sustaining 
of high plasma ghrelin concentration may not be effective to increase plasma GH 
concentration.  In the present study, plasma GH concentration was not increased by 
41% rises in plasma ghrelin concentration, but 9 to 19% rises in plasma ghrelin 
concentration induced high plasma GH concentration after 14 d treatment.  The 
moderate continuous increase of plasma ghrelin concentration may be effective in case 
requiring a persistent increase in plasma GH concentration.  Increased plasma ghrelin 
concentration did not contribute to the increase in plasma IGF-1 concentration in both 
Chapters 3 and 4.  Twenty-four hour continuous infusion of ghrelin increased plasma 
IGF-1 concentration with high plasma GH concentration in human (Veldhuis et al., 
2008).  However, in the long-term period, plasma IGF-1 concentration is positively 
correlated with protein intake (Law et al., 2009) and energy balance (Pedernera et al., 
2008).  Although GH stimulates IGF-1 synthesis in the liver, the GH receptor 
abundance is regulated by the energy intake level and a limiting factor for plasma 
IGF-1 concentration (Rhoads et al., 2007).  Actually, plasma IGF-1 concentration is 
not consistent with plasma GH concentration in lactating period.  Butler et al. (2003) 
demonstrated hyperinsulinemic euglycemic clamp for 96 h increased plasma IGF-1 
concentration with high expression of GH receptor mRNA.  In the present study, 
plasma insulin concentration decreased with MCFA and LCFA, suggesting the low 
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plasma IGF-1 concentration related to plasma insulin concentration rather than plasma 
ghrelin and GH concentrations. 
     Plasma glucagon and insulin concentrations were also modified by feeding 
MCFA, LCFA and LCFA plus Met.  Unlike obtained results in Chapter 2, high plasma 
ghrelin concentration by feeding MCFA and LCFA did not increase plasma glucagon 
and insulin concentrations.  The decrease in plasma insulin concentration in MCFA 
and LCFA treatments are possibly associated with lower plasma GLP-1 concentration 
and DMI, and are altered by rumen fermentation rather than by plasma ghrelin 
concentration.  However, plasma glucagon and insulin concentrations were increased 
when cows were fed LCFA plus Met than when cows were fed LCFA only.  The result 
resembles the result in Chapter 2 where amino acids enhanced glucagon and insulin 
secretion induced by ghrelin injection.  
 
 
5.4. A role of ghrelin in regulating lactation. 
Ghrelin has catabolic function (stimulating GH secretion) and anabolic function 
(enhancing appetite and fat deposition) in laboratory animals.  It has been unclear 
how ghrelin acts in lactating cows.  In Chaper 2, amino acids did not affect plasma 
ghrelin concentration, but altered ghrelin action.  In the study, amino acids stimulated 
insulin secretion and glucose removal after ghrelin injection.  Although milk 
production was not observed in this experiment due to a short-term infusion, providing 
more amino acids to lactating cows in the state of negative energy balance may lead to 
restore insulin resistance.  In Chapters 3 and 4, feeding MCFA and LCFA plus Met 
did not increase milk production despite of the increase in endogenous plasma ghrelin 
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concentration.  However, MCFA could increase milk production with high plasma 
ghrelin concentration if MEI were equivalent to the control diet.  In Chapter 4, using 
mid-lactating cows, plasma ghrelin and GH concentrations were increased by feeding 
LCFA and LCFA plus Met without the increase in milk production.  As same as in 
Chapter 3, feeding LCFA and LCFA plus Met may also bring some effects to milk 
production in early-lactating period. 
 
In conclusion, the nutritional treatment in this study succeeded in increasing 
plasma ghrelin concentration.  However, the endogenous increase in plasma ghrelin 
concentration did not always result in an increase in plasma GH concentration.  
Additionally, the nutritional strategy for stimulating ghrelin secretion did not 
contribute to enhancing milk production, but some possibilities to modify milk 
production could be found out because of manipulating endogenous ghrelin secretion 
by nutritional treatments was accompanied with several alterations of metabolic 
hormones and nutrient metabolism.  The feed supplements such as MCFA or LCFA 
plus Met may lead to higher milk production when the supplements are fed in the other 
lactating stage or for a prolonged period. 
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Table 5-1. The summary of the results of 3 studies
Item Amino acid mixture* MCFA-Ca1* LCFA-Ca2* LCFA-Ca+Met3†
DMI4  ー5  ↓ ↓ →
Milk yield ー → → →
Plasma concentrations of hormones and metabolites
  Ghrelin NS ↑↑ ↑ ↑
  GH6 NS → → →
  IGF-17 ー ↓ ↓ ↓
  GLP-18 ー →
→ →
  Glucagon NS → ↓ →
  Insulin NS ↓ ↓ →
  Glucose NS ↓ → ↑
  BHBA9 ー ↑ ↓ →
  NEFA10 NS ↑ ↑ ↓
  TG11 ー ー ↑ ↓
  T-CHO12 ー ↑ ↑ ↓
  UN13 ー ↑ ↑ →
Ghrelin action14
  GH → → ー ー
  Insulin ↑ → ー ー
  Glucagon ↑ → ー ー
  Glucose ↓ → ー ー
  NEFA → → ー ー
1MCFA = medium-chain fatty acids.
2LCFA = long-chain fatty acids.
3Met = methionine.
4DMI = dry matter intake.
5ー: Not tested in the study.
6GH = growth hormone.
7IGF-1 = insulin-like growth factor-1
8GLP-1= glucagon-like peptide-1 (7-36) amide.
9BHBA = beta-hydroxy butyrate.
10NEFA = non-esterified fatty acids.
11TG = triglyceride.
12T-CHO = total-cholesterol.
13UN = urea nitrogen.
14The area under curve or incremental area of each hormone and metabolites after ghrelin injection.
*Compared with the control treatment.
†Compared with LCFA-Ca treatment.
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Chapter 6 
 
 
General Summary 
 
Feed intake and metabolic use of nutrients are important factors to maximize 
milk production of lactating dairy cows, and they are partly regulated by metabolic 
hormones.  Growth hormone (GH) is well documented for the increase in milk 
production through some metabolic regulation to promote lipolysis in the adipose 
tissue and to enhance gluconeogenesis and biosynthesize of insulin-like growth 
factor-1 (IGF-1) in the liver.  IGF-1 has a galactopoietic effect with increasing blood 
flow into the mammary gland and with causing insulin resistance.  Thus, GH plays a 
central role in regulating milk production in lactating cows, and hence, the approach to 
enhance the endogenous GH secretion potentially leads to the increase in milk 
production.  However, such approach has been not established because GH secretion 
is strongly regulated by central nervous systems.  Ghrelin, secreted from the 
gastrointestinal tract, was identified as a potent GH secretagogue in recent years.  In 
addition, ghrelin is related to appetite regulation; ghrelin injection increases the food 
intake in laboratory animals.  Because circulating ghrelin is sensitive to ingested 
nutrients, hence the nutritional management or feeding strategy to control ghrelin 
secretion may be able to adjust the GH secretion.  The previous study demonstrated 
that plasma ghrelin concentration in ruminants was decreased by volatile fatty acids, 
and was not affected by glucose as a secretory inhibitor in non-ruminants.  Another 
previous study revealed that plasma ghrelin concentration was increased by amino 
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acids in sheep.  However, there has been still little information of which nutrients 
affect plasma ghrelin concentration in ruminants.  The objectives of this study were to 
determine the effects of some nutrients on plasma ghrelin concentration and 
ghrelin-induced metabolic changes, and to consider ghrelin’s role in controlling milk 
production of lactating cows. 
In the 1st trial, the effects of amino acids on plasma ghrelin concentration and 
ghrelin action were investigated in lactating cows.  A mixture solution of amino acids 
(AMI) or saline (CON) were intravenously infused to determine plasma ghrelin 
concentration, and after then, during the infusion of AMI or CON, ghrelin was 
intravenously injected to determine the ghrelin action.  In this experiment, six 
lactating Holstein cows were randomly assigned to two infusion treatments (AMI or 
CON) in a cross-over design.  There was no difference in plasma ghrelin 
concentration between AMI and CON before the ghrelin injection.  After the ghrelin 
injection, plasma GH, glucose, and non-esterified fatty acids (NEFA) concentrations in 
comparison with before injection immediately increased (P < 0.05) with no difference 
between two infusion treatments.  Plasma insulin and glucagon concentrations were 
also increased by ghrelin injection in two infusion treatments (P < 0.05).  The peak 
value of plasma insulin concentration was greater in AMI compared with CON (P < 
0.05).  Plasma glucagon concentration showed no difference at the peak value 
reached at 5 min in both treatments, and after then, showed sustained higher values in 
AMI compared with CON (P < 0.05).  After plasma glucose concentration reached 
the peak, the degree of decline was greater in AMI compared with CON (P < 0.05).  
These results indicated that the plasma amino acids directly do not affect plasma 
ghrelin concentration, but may modify the ghrelin actions; amino acids which stimulate 
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glucagon, insulin, and glucose release into the blood circulation. 
In the 2nd trial, the effects of medium-chain fatty acids (MCFA) on plasma 
ghrelin, GH, other metabolic hormone, metabolite concentrations, and milk production 
were investigated.  Five early-lactating Holstein cows were randomly assigned to two 
dietary treatments in a cross-over design for 2-week periods.  The diets were with a 
supplement of MCFA (MCFA-Ca, 1.5% added on dry matter basis) and without 
MCFA-Ca (CON).  Plasma concentrations of hormones and metabolites in jugular 
vein were measured around the morning feeding on day 14 of each period.  Dry 
matter intake (DMI) and metabolizable energy intake (MEI) were decreased, and milk 
yield tended to be decreased in the MCFA-Ca compared with CON diet (P < 0.05).  
Milk protein and lactose contents were decreased in the MCFA-Ca diet (P < 0.05).  
The MCFA-Ca diet increased plasma ghrelin concentration (P < 0.05), but did not 
affect plasma GH concentration, and decreased plasma IGF-1 concentration (P < 0.05).  
The MCFA-Ca diet did not affect plasma glucagon-like peptide-1 (7-36) amide 
(GLP-1) concentration.  Plasma insulin concentration was decreased (P < 0.05), and 
plasma glucagon concentration was not changed with the MCFA-Ca diet.  Plasma 
NEFA, total cholesterol (T-CHO) and beta-hydroxy butyrate (BHBA) concentrations 
were increased in the MCFA-Ca diet (P < 0.05).  In conclusion, although plasma GH 
concentration did not link plasma ghrelin concentration, the MCFA diet increased 
plasma ghrelin concentration in lactating cows. 
In the 3rd trial, the effects of long-chain fatty acids (LCFA) and methionine 
(Met) on plasma ghrelin, GH, other metabolic hormone, metabolite concentrations, and 
milk production were investigated.  Four lactation Holstein cows were used in a 4 x 4 
Latin square experiment for each 2-week period.  Cows were fed diets with 
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supplements of calcium salts of LCFA (LCFA-Ca, 1.5% added on dry matter basis), 
rumen-protected Met (RPM, 20 g/d), LCFA-Ca plus RPM and without supplements 
(CON).  Jugular blood samples were taken from 1 h before to 2 h after morning 
feeding at 10 min intervals on day 12 of each period.  The LCFA-Ca decreased DMI 
(P < 0.05), but RPM did not affect DMI.  Both supplements of LCFA-Ca and RPM 
did not affect MEI and milk yield and composition.  Plasma concentrations of NEFA, 
triglyceride (TG), and T-CHO were increased with LCFA-Ca alone (P < 0.05), but the 
degrees of increases in plasma TG and T-CHO concentrations were moderated by 
LCFA-Ca plus RPM (P < 0.05).  The LCFA-Ca increased plasma ghrelin 
concentration (P < 0.05) and the ghrelin concentration with LCFA-Ca plus RPM was 
the highest among the treatments.  Similarly, plasma GH concentration tended to be 
increased by LCFA-Ca (P = 0.056) and showed the highest level in LCFA-Ca plus 
RPM.  On the other hand, plasma IGF-1 concentration was decreased by LCFA-Ca 
and RPM (P < 0.05).  Plasma GLP-1, glucagon, and insulin concentrations were 
decreased with LCFA-Ca (P < 0.05), whereas there was the interaction between 
LCFA-Ca and RPM in plasma glucagon concentration (P < 0.05); the LCFA-Ca plus 
RPM mitigated the decrease of plasma glucagon concentration by LCFA-Ca.  These 
results showed that the supplementation of RPM together with LCFA-Ca increases 
plasma ghrelin and glucagon concentrations.  Although the GH concentration was 
linked with plasma ghrelin concentration, plasma IGF-1 concentration was not 
associated with plasma GH and ghrelin concentrations.  
     In lactating cows, the exogenous ghrelin injection shows certain catabolic effects 
such as stimulating GH and glucagon secretions, associated with NEFA and glucose 
releases into the circulation in lactating cows.  This study showed that amino acids 
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did not affect plasma ghrelin concentration, but modified these ghrelin actions; 
ghrelin-induced glucagon and insulin secretions were augmented, and simultaneous 
glucose removal from the circulation was enhanced by amino acids.  This suggests 
amino acids may counteract the catabolic action of ghrelin.  The present study 
demonstrated that plasma ghrelin concentration varies according to the kinds of 
available nutrient.  MCFA increased plasma ghrelin concentration because they are 
directly used for acylation of ghrelin.  LCFA also increased plasma ghrelin 
concentration.  When Met was fed with LCFA, plasma ghrelin concentration was 
further increased.  This might be caused not by a direct action of Met, but by the 
indirect action of Met because Met modulates lipid metabolism.  The incremental 
degree of plasma ghrelin concentration was greater in cows fed MCFA (43%) 
compared with cows fed LCFA plus Met (19%).  Nonetheless, the endogenous 
increase in plasma ghrelin concentration did not increase plasma GH concentration in 
cows fed MCFA, but increased in cows fed LCFA plus Met.  The present study 
showed that continuous hyper plasma ghrelin concentration did not increase GH 
secretion always, suggesting that keeping of plasma ghrelin concentration above 
threshold level is not effective for the stimulation of GH secretion.  The increased 
plasma ghrelin concentration by LCFA plus Met might be also related to some 
metabolic changes such as the higher plasma glucagon and glucose concentrations. 
In conclusion, the kind of available nutrients affect plasma concentration and 
action of ghrelin in lactating cows.  Milk production is not enhanced by the feed 
supplements as MCFA and LCFA because of their adverse effect on feed intake.  
However, the changes in plasma ghrelin concentration induced by these feed 
supplements could mediate major metabolic hormones to control nutrients use in the 
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whole body of lactating cows. 
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Abbreviations 
 
AAN: alpha-amino nitrogen 
AUC: area under the curve 
BW: body weight 
CP: crude protein 
d: day 
DIM: days in milk 
DM: dry matter 
DMI: dry matter intake 
EE: ether extract 
Eu: Europium 
FA: fatty acids 
FCM: fat correct milk 
g: gravity 
GH: growth hormone 
GHRH: growth hormone releasing hormone 
GHS: growth hormone secretagogue 
GHS-R: gwowth hormone secretagogue receptor 
GLP-1: glucagon-like peptide-1 (7-36) amide 
GPR-120: G-protein coupled receptor-120 
h: hour 
IGF-1: insulin-like growth factor-1 
KIU: kilo inhibitor unit 
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LCFA: long-chain fatty acids 
LCFA-Ca: calcium salts of long-chain fatty acids 
MCFA: medium-chain fatty acids 
MCFA-Ca: calcium salts of medium-chain fatty acids 
ME: metabolizable energy 
MEI: metabolizable energy intake 
Met: methionine 
min: minute 
N: nitrogen 
NDF: neutral detergent fiber 
NEFA: non-esterified fatty acids 
OM: organic matter 
rbGH: recombinant bovine GH 
RPM: rumen protected methionine 
SNF: solid non fat 
T-CHO: total-cholesterol 
TG: triglyceride 
TR-FIA: time-resolved fluoroimmunoassay  
TS: total solid 
UN: urea nitrogen 
 
 
